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ABSTRACT 
Congenital adrenal hyperplasia (CAH) is a disorder of steroid genesis affecting 
approximately 1:10 000 children and leading to increased levels of androgens during 
foetal life and subsequent virilization of external genitalia in affected girls. However, 
prenatal virilization can be eliminated by antenatal dexamethasone (DEX) treatment. To 
be fully effective, DEX treatment has to be started in the 6–7th postmenstrual week and 
continued until the results of the prenatal diagnosis are available at gestational week 11–
12. This means that 7 out of 8 foetuses (boys and unaffected girls) are treated 
unnecessarily during early gestation. CAH-affected girls are treated to term.  
 
We performed a long-term follow-up of children treated in Sweden during the years 
1985–1995, and 26 of the 40 treated individuals participated in the study. The control 
group consisted of 35 sex- and age-matched healthy children.  
 
In general, the DEX-treated children were as well adjusted as the controls (Studies I and 
II). There were no between-group differences in major cognitive measures such as IQ, 
learning and memory. Parents reported that the DEX-treated children performed just as 
well at school as the controls. However, in a test of verbal working memory (WM), 
significantly lower results were observed in CAH-unaffected short-term treated children. 
The CAH-affected children did not differ from the control group, probably owing to small 
sample size and, consequently, low power. The verbal WM was correlated with the 
children‟s self-perception of difficulties in scholastic ability, another measure in which 
CAH-unaffected children differed from the controls. In measures of temperament, 
psychopathology and well-being, parents reported generally as good health in the DEX- 
exposed group as in the control group. The only difference was an observed increase in 
sociability in DEX-exposed children. In the children‟s self-ratings, however, increased 
social anxiety was observed. This difference was significant in CAH-unaffected short-
term-treated children.  
 
In order to study gender role behaviour (Studies III and IV), we developed a new 
instrument, the Karolinska Inventory of Gender Role Behaviour (KI-GRB), which was 
evaluated in an additional group of 180 school-age children. The underlying dimensions 
of the inventory were described by the factor structure and the KI-GRB subscales were 
also associated with sex-specific cognition. In prenatally DEX-exposed, CAH-unaffected 
boys, more neutral behaviours were observed, while in girls no group differences emerged 
after controlling for site of residence. A similar pattern was found when CAH-affected 
children were included in the analyses 
 
In summary, these studies indicate that prenatal DEX treatment of CAH may have 
negative effects on certain aspects of cognitive and affective development, as well as 
affect gender role behaviour.  
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1 INTRODUCTION 
Glucocorticoids (GCs) affect a range of somatic and mental processes. The focus of 
this thesis is on how prenatal exposure to the synthetic GC dexamethasone (DEX) 
affects the function of the central nervous system, measured as cognitive 
performance, well-being, gender role behaviour and other aspects of behaviour. The 
clinical group studied consists of children at risk for congenital adrenal hyperplasia 
(CAH) exposed prenatally to DEX.  
 
1.1 CONGENITAL ADRENAL HYPERPLASIA (CAH) 
The diagnostic term congenital adrenal hyperplasia (CAH) applies to a family of 
inherited disorders of steroid genesis caused by an abnormality in one of the five 
necessary enzymatic steps in the conversion of cholesterol to cortisol. Cortisol (the 
endogenous GC), aldosterone (the salt-retaining hormone) and testosterone are all 
steroids derived from cholesterol, and many of the same enzymes are used for their 
synthesis in the adrenal cortex. Cortisol synthesis is normally regulated by a negative 
feedback loop in which high serum levels of cortisol inhibit the synthesis and/or 
release of corticotropin-releasing hormone (CRH) at the level of the hypothalamic 
paraventricular nucleus and adrenocorticotropin hormone (ACTH) from the pituitary, 
whereas low serum levels of cortisol stimulate the release of CRH and ACTH. This 
loop defines the hypothalamic-pituitary-adrenal axis (HPA axis). 
In more than 95% of cases CAH is caused by a 21-hydroxylase deficiency 
(21OHD) due to mutations in the 21-hydroxylase gene (CYP21A2). The CYP21A2 is 
located on the short arm of chromosome 6, and the disorder has an autosomal 
recessive mode of inheritance (Figure 1). Postnatally, individuals with CAH receive 
life-long medication with synthetic GC, such as prednisolone. Individuals with milder 
forms of CAH sometimes only need synthetic GC medication, while in more severe 
CAH, when the 21OHD enzyme block is more complete, fludrocortisone must also 
be taken in order to avoid salt loss.   
CAH is a rare condition affecting approximately 1:10 000 children in Sweden. 
Thus each year, 10–15 children are diagnosed with CAH.  
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Figure 1. CAH has an autosomal recessive pattern of inheritance, meaning that one out of 
four children is affected with CAH in families with two unaffected “carrier” parents. 
Thus, one out of eight children is a CAH-affected girl.  
The clinical symptoms of CAH range from mild disease (non-classical CAH, 
NC) that may present as late as in adult life in women with hirsutism and infertility to 
more severe prenatally virilizing forms without (simple virilizing CAH, SV) or with 
salt loss (salt-wasting CAH, SW). Three fourths of individuals with classical CAH 
are salt-wasting, i.e. have an aldosterone deficiency. The salt-wasting variant is 
characterized by a more complete block of the enzyme 21-hydrozylase, which 
generates higher androgen levels and is associated with increased genital virilization. 
Thus, depending on the type of CAH, the prenatal hormonal milieu and, 
consequently, degree of virilization can be predicted in future pregnancies (i.e. the 
genotype predicts the phenotype) (Lajic, Nordenstrom, Ritzen, & Wedell, 2004). 
The newborn girl with virilizing CAH (SV or SW) can in the most severe 
cases be taken for a boy due to clitoromegaly, labioscrotal fusion and formation of a 
urogenital sinus. The virilization is due to increased production of androgen 
precursors (dehydroepiandrosterone DHEA/dehydroepiandrosterone sulphate DHEA-
S, as well as androstenedione) in the adrenal cortex and their conversion to the potent 
androgens testosterone and dihydrotestosterone (DHT) (Figure 2).  
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Figure 2. A simplified adrenal pathway and major steroid hormones in CAH. In most of 
the cases CAH is caused by a 21-hydroxylase deficiency (21OHD) due to mutations in the 
21-hydroxylase gene (CYP21A2). 21-hydroxylase is one of the enzymes necessary in the 
conversion of cholesterol to cortisol. Low levels of cortisol are a signal for the brain to 
increase cortisol synthesis (increase the activity of the HPA axis), which, in the case of 
21-hydroxylase deficiency, leads to excessive synthesis of androgens of adrenal origin.  
 
Females with CAH are fertile with a potential for pregnancy when treated 
with life-long glucocorticoid replacement and surgical correction of the external 
genitalia. A common treatment policy recommends an establishment of the definitive 
endocrine diagnosis and treatment as early as possible, assignment of the infant to 
female gender and feminizing surgery of the virilized external genitalia 
(LWPES/ESPE, 2002).  
To have a child with genital ambiguity is a traumatizing experience for the 
family. In addition, the reconstructive surgery can cause great emotional stress for 
both the child and her family. Moreover, the surgical outcome and sexual function are 
not always optimal, especially in females who are severely virilized (Nordenstrom et 
al., 2010). The fertility rate is still low in women with CAH, although it has improved 
significantly during the past years owing to earlier treatment of CAH, as well as 
surgical advances in genital reconstruction (Lo & Grumbach, 2001). Women with 
CAH report relatively low levels of sexual activity (although in an uncontrolled 
study) (Morgan, Murphy, Lacey, & Conway, 2005). The sexual debut occurs two 
years later among women with CAH as compared to controls (Frisen et al., 2009). In 
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the same study, 13% of women with CAH had not debuted sexually, as compared to 
less than 2% in the age-matched control group (ibid.).  
The genital malformations in CAH can nowadays be reduced by prenatal 
treatment with DEX and, consequently, reconstructive surgery can be avoided (Lajic, 
et al., 2004). 
1.2 PRENATAL DEXAMETHASONE TREATMENT OF CHILDREN AT 
RISK FOR CAH 
Prenatal treatment with dexamethasone (DEX) has been administered since the mid-
1980s to reduce the genital malformations and thereby avoid reconstructive surgery 
(Chrousos et al., 1985; David & Forest, 1984). The rationale for prenatal DEX 
treatment of foetuses at risk for CAH is to suppress the foetal adrenal cortex in order 
to reduce the levels of adrenal androgens and thus normalize sex differentiation in 
female foetuses with SV or SW CAH. 
Virilization of external genitalia by androgens occurs from 6 to 8 weeks of 
gestation. To be fully effective, DEX treatment has to be started in the 6
th–7th 
postmenstrual week and continued until the results of the prenatal diagnosis are 
available (generally by CYP21A2 genotyping of foetal DNA obtained by chorionic 
villus sampling, CVS, in gestational weeks 11–12). This means that 7 out of 8 
foetuses (boys and unaffected girls) are treated unnecessarily during early gestation. 
Girls with CAH are treated until term. Treatment safety has been reported to be 
acceptable, at least in the short-term perspective, based on findings of normal pre- 
and postnatal growth, and the reported side-effects do not appear to follow a 
particular pattern (Lajic, et al., 2004). Nevertheless, long-term effects are just starting 
to be addressed due to the fact that the oldest children treated are now reaching early 
adulthood. Results from experimental animal models have also raised concerns 
regarding possible future effects on metabolism, cognition and emotional 
development in adult life (de Vries et al., 2007; Hauser et al., 2008; Matthews, 2001; 
Seckl, 2004). 
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Figure 3. The treatment protocol for the prenatal dexamethasone treatment of children at 
risk for congenital adrenal hyperplasia. 
 
1.2.1 Maternal side-effects of prenatal DEX treatment 
The focus of this thesis is on prenatally DEX-treated children, while follow-ups of 
mothers have been reported in detail elsewhere (Ritzén, 2001; "Technical report: 
congenital adrenal hyperplasia. Section on Endocrinology and Committee on 
Genetics," 2000). Reported maternal adverse effects have been marked weight gain, 
mood swings, nervousness, irritability, hypertension, glucose intolerance and severe 
striae with permanent scarring, chronic epigastric pain, gastroenteritis, increased 
facial hair growth and cushingoid facial features (ibid). Increased weight gain during 
the first trimester and more cutaneous striae were the only statistically significant 
differences between the dexamethasone-treated mothers and controls in the only 
controlled (retrospective) study (Lajic, Wedell, Bui, Ritzen, & Holst, 1998). 
However, the discrepancy in weight between treated women and their controls had 
disappeared by the end of the pregnancy.  There was a tendency for mothers treated 
full-term (7 cases) to report more side-effects than those treated only during the first 
trimester of pregnancy. One third of the Swedish mothers who received 
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dexamethasone treatment in the study by Lajic et al. (1998) would not choose 
treatment in a future pregnancy. In other studies (Forest, David, & Morel, 1993; 
Mercado, Wilson, Cheng, Wei, & New, 1995), almost all the mothers said that they 
would choose to undergo the same treatment during a next pregnancy.  
 
1.3 FOETAL CNS DEVELOPMENT DURING EARLY GESTATION  
The central nervous system (CNS) is particularly sensitive during foetal development. 
A major negative impact on the foetal CNS can be associated with gross alterations in 
CNS structure and functioning, while subclinical effects can result in developmental 
delay and lower scores on measures of CNS functioning such as IQ. Subtle effects on 
CNS functioning may not even be captured by routine neuropsychological 
assessment, despite an impact on the child‟s everyday life when the challenge level is 
increased, such as multitasking, distraction and/or new tasks (Dennis, 2000).  
Generally, drugs affect the foetal brain at lower doses than in the case of 
adults. Different aspects of the CNS are affected depending on the developmental 
phase of the foetus. In early embryonic development cell proliferation occurs within 
the neural tube and by week 5 of gestation, the basic features of the CNS can be 
identified. After 6 weeks of gestation, the neuroblasts begin to migrate to their 
permanent locations, where the differentiation begins. Neuronal differentiation 
includes processes such as development of cell bodies, selective cell death, dendritic 
and axonal growth, and synaptogenesis (Anderson, Northam, Hendy, & Wrennall, 
2001; Jessell & Sanes, 2000). Between the 6
th
 and 12
th
 gestational week many regions 
of the brain develop, such as the dopaminergic nuclei in the midbrain, the 
hypothalamic areas and certain areas of the hippocampus, as well as areas of the 
striatum, amygdala and neocortex (Bayer, Altman, Russo, & Zhang, 1993).  
In the foetal CNS, glucocorticoids are essential for normal brain development 
affecting such processes as cell proliferation and neuronal growth and differentiation 
(Matthews, 2001), modulating neurotransmitter systems and regulating the plasticity 
and circuitry, as well as affecting (supressing) myelin content in the brain (Belanoff, 
Gross, Yager, & Schatzberg, 2001). Excessive GC levels are known to be detrimental 
to the foetal CNS. Foetal exposure to excess GC can be of different origins, such as 
maternal stress or maternal treatment with synthetic GC. 
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1.4 GLUCOCORTICOIDS 
The endogenous glucocorticoid (cortisol, hydrocortisone) is essential for life in 
regulating or supporting several important metabolic, immunological, cardiovascular 
and homeostatic functions. In addition to DEX, several synthetic GCs have been 
developed for therapeutic use, and the synthetic GCs differ in pharmacokinetics (such 
as half-life) and pharmacodynamics (such as mineralocorticoid potency). GCs act via 
two types of receptors: the mineralocorticoid receptor (MR) and the glucocorticoid 
receptor (GR).   
Cortisol has a 10 times higher affinity for the MR than for the GR (De Kloet, 
Vreugdenhil, Oitzl, & Joels, 1998), which is why the MRs are occupied in a non-
stress baseline state while the GR become occupied when the levels of free cortisol 
rise, i.e. during a stress response. However, DEX binds predominantly to the GR 
regardless of the state of the organism.  
The MR is expressed primarily in the limbic system, while the GR is present 
in both subcortical and cortical structures with the highest density being found in the 
hippocampus, parahippocampal gyrus, paraventricular nucleus and other 
hypothalamic nuclei, as well as the cortex (McEwen et al., 1987). Thus, cortisol is 
normally regulated by the hypothalamic-pituitary-adrenal axis (HPA axis) (Figure 4) 
while further control of HPA axis activity occurs at extrahypothalamic sites such as 
the hippocampus and the amygdala. In primates the prefrontal cortex is particularly 
dense in GRs (Patel et al., 2000; Sanchez, Young, Plotsky, & Insel, 2000).  
The hippocampus is not only involved in regulation of stress and the HPA 
axis, but also in learning and long-term memory (Kandel, Kupfermann, & Iversen, 
2000). The amygdala is associated with processing of emotional information, for 
example fear, as well as social information, such as facial expressions (Iversen, 
Kupfermann, & Kandel, 2000). The prefrontal cortex is involved in the regulation of 
behaviour (executive control), with regard to motor as well as cognitive and affective 
processes (Gazzaniga, Ivry, & Mangun, 1998) (chapter 11, p. 423–464). Thus, a wide 
range of cognitive and affective processes can be influenced by GCs (see also the 
section Brain development in CAH).  
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Table 1. Timetables of neurogenesis in selected brain regions in the rat and human foetus 
(adapted from Bayer et al., 1993). 
 
CNS region 
 
Rat embryonic (E)  
or postnatal (P)  
age in days 
Human foetal 
age  
in weeks 
Pontine and Medullary Nuclei   
Locus coeruleus E11-E13 3.5-5.7 
Raphe nuclei E11-E15 3.5-7.0 
Reticular formation E11-E15 4.1-7.0 
Midbrain Dopaminergic Nuclei   
Substantia nigra (compacta and reticulata) E13-E15 5.3-7.0 
Ventral tegmental areas (lateral and medial)  E13-E16 5.3-7.4 
Amygdala (most areas) E13-E17 5.3-7.9 
Thalamus E13-E18 5.3-9.9 
Hypothalamic Region   
Hypothalamus proper (most areas) E13-E18 5.3-9.9 
Lateral and medial preoptic areas E12-E17 4.1-7.9 
Periventricular  E15-E19 6.7-14.9 
Sexually dimorphic nuclei E15-E19 6.7-14.9 
Hippocampal Region   
Entorhinal cortex and subiculum E14-E19 5.8-11.9 
Hippocampus (CA1, CA3ab, CA3c) E16-E20 7.1-14.9 
Dentate granule cells P0-P15 19-35.9 
Striatum and Pallidum   
Pallidum E12-E16 4.1-7.4 
Striatum (Caudoputamen complex and n. accumbens) E16-E22 7.1-18.9 
Neocortex and limbic cortex   
Most neocortical and limbic cortical neurons E 14-E20 5.8-14.9 
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Thus, the activity of the HPA axis mediates physical “allostasis”, the adaptive 
responses of the body that maintains homeostasis in response to stress, but it is also 
essential for modulation of behavioural adaptation during acute stress, and regulates 
arousal, alertness, and cognition (Charmandari, Kino, Souvatzoglou, & Chrousos, 
2003; Lupien et al., 2002). The “allostasis” is not only produced by mediators 
generated by the HPA axis but also by the immune system and the autonomic nervous 
system (ANS). The brain is both a controller and a target of the three systems, and 
also effectuates allostatic processes by activation of nerve cells and release of 
neurotransmitters (McEwen, 2002).  
1.4.1 The connection of the HPA axis to the SAM 
The HPA axis activity is bidirectionally connected to the sympathetic-adrenomedullar 
system (SAM), which mediates a variety of rapid, visceral responses to stress, such as 
heart rate and vasoconstriction. Cortisol increases the rate and strength of heart 
contractions, sensitizes blood vessels to the action of noradrenaline and affects many 
metabolic functions. These actions prepare the body (and mind) to meet a stressful 
situation. The emergency reaction, or fight-or-flight reaction, is mediated by 
catecholamines. In the CNS, the SAM is regulated by the hypothalamus, which also 
regulates the HPA axis, and thus the secretion of cortisol in the endocrine stress 
response. There are a number of other physiological mediators that are also activated 
during a stress response and are adaptive in the short run. When the allostatic systems 
remain turned on during a longer period of time, e.g. during prolonged stress, the 
mediators can produce a wear and tear on the body and the brain, an “allostatic load”, 
which can be damaging for the organism (McEwen, 2002).  
Like the activity of the HPA axis, SAM also regulates the cognitive state and 
specific cognitive functions in order to facilitate the individual‟s ability to cope with 
acute stress. The self-perceived coping ability, in turn, strongly affects the 
perceptions of stress and, in addition, the activity in both the HPA axis and SAM. 
Thus, the stress reactivity may affect both cognitive performance and affective 
reactions to a stressor (Kapoor, Petropoulos, & Matthews, 2008). 
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Figure 4. The hypothalamic-pituitary-adrenal axis activity is bidirectionally connected to 
the sympathetic-adrenomedullar system.  
Note: CRH = corticotropin-releasing hormone; ACTH = adrenocorticotropin hormone; 
NA = noradrenaline. 
 
 
1.4.2 Behavioural effects of excessive glucocorticoids 
GC signalling may have different effects in a mature versus a developing brain, and 
prenatal exposure to excess GC has yet other consequences (McEwen, et al., 1987). 
The effects on the adult CNS are often reversible, at least to some degree, while 
effects on a foetus can be organizational, i.e. have an imprinting effect and 
“programming” of the behaviour and certain physiological functions for long periods 
of time and even for the entire life span of the individual (Charmandari, et al., 2003). 
It should be noted that behavioural effects including cognition are not necessarily 
mediated by structural changes in the brain, since the activity of the HPA axis is 
essential for modulation of behavioural adaptation during acute stress and regulates 
arousal, alertness and cognition (Charmandari, et al., 2003; Lupien, et al., 2002). 
Thus, permanent changes in the reactivity of the HPA axis program both cognitive 
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performance and emotional reactions in the affected individual (Charmandari, et al., 
2003; Kapoor, et al., 2008). 
1.4.2.1 Effects of glucocorticoids in adults 
In a normal daily fluctuation of cortisol, an increase is seen in the morning after 
awakening (awakening cortisol response, ACR), after which levels successively 
decrease during the day (Clow, Thorn, Evans, & Hucklebridge, 2004). Both low 
(Heim, Ehlert, & Hellhammer, 2000) and high cortisol concentrations (Bauer et al., 
2000; Kirschbaum et al., 1995), as well as aberrant ACR (Clow, et al., 2004), have 
been associated with chronic stress. Although seemingly inconsistent, these results 
may be logical in view of the fact that HPA axis reactivity is affected by several 
factors that may differ in different study populations, such as season of the 
measurement (J. A. King et al., 2000); awakening time (Clow, et al., 2004); age and 
gender (S. L. King & Hegadoren, 2002); the individual‟s IQ (Tennes & Kreye, 1985); 
nicotine abuse (Kirschbaum & Hellhammer, 1994); psychiatric illness, such as 
depression (Burke, Davis, Otte, & Mohr, 2005; Jansen et al., 1999), anxiety 
(McBurnett et al., 1991; van Goozen et al., 1998), post-traumatic stress disorder 
(Heim, et al., 2000); as well as psychoactive drugs  (Joyce, Donald, Nicholls, 
Livesey, & Abbott, 1986; Kariyawasam, Zaw, & Handley, 2002).  
In adults, excessive GC has been studied in diseases such as Cushing‟s 
syndrome (an endocrine disorder characterized by sustained hypercortisolism, either 
due to an endogenous overproduction of cortisol or medical treatment with synthetic 
GC), as well as in healthy subjects in an experimental design using synthetic GC [for 
a review, see (Belanoff, et al., 2001)]. Most studies on negative effects of GC have 
focused on high rather than low GC levels, although too low levels of cortisol are also 
thought to be negative for the CNS (ibid.).  
The structural effects of excessive endogenous or exogenous GC have 
consisted in a higher ventricle-brain ratio, enlargement of ventricles and hippocampal 
atrophy, as well as cerebral and cerebellar cortical atrophy (ibid.). Among psychiatric 
symptoms, excessive GC may increase the risk for depression, anxiety and agitation 
(Belanoff, et al., 2001). A wide range of cognitive effects have also been 
demonstrated such as negative effects on general intellectual ability, memory, visual 
and spatial reasoning, concentration, attention and distractibility, as well as impulse 
inhibition, working memory and other executive functions (Belanoff, et al., 2001). 
Thus, exposure to prolonged stress or high levels of GC impair prefrontal cognitive 
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functions (Arnsten, 1999). However, short-term stress can enhance cognitive 
functions, such as attention and memory (Lupien, Gillin, & Hauger, 1999), as well as 
executive functions (Hirvikoski et al., 2011), thus facilitating the individual‟s ability 
to cope with stress. In theory, both poor recovery (repeatedly sustained high cortisol 
levels after a stressor) and abnormally low stress reactivity (low cortisol) could 
worsen the individual‟s ability to cope with stressors in everyday life.  
It should be noted, however, that the association between stress and cognition 
may also be related to the SAM, and not only GC (Figure 4). Different kinds of 
stressors elicit stress (Cinciripini, 1986; Kirschbaum, Pirke, & Hellhammer, 1993; 
McEwen, 2006), but physiological stress responses may not be identical to different 
types of stressors (stimulus-response specificity) (Lundberg & Frankenhaeuser, 
1980). For example, cognitive stressors drive predominantly stress responses from the 
autonomic nervous system (ANS) (Lundberg & Frankenhaeuser, 1980).   
1.4.2.2 Effects of glucocorticoids in children  
There are few studies on the effects of exogenous administration of GCs on cognitive 
performance in children, for obvious ethical reasons. Administration of high-dose 
prednisone to children with chronic asthma caused more severe impairment of verbal 
memory, as well as more symptoms of anxiety and depression than low doses 
(Bender, Lerner, & Poland, 1991). Synthetic GCs used in the (postnatal) treatment of 
CAH have been considered to be the most reasonable explanation for the white-
matter abnormalities and/or temporal lobe atrophy observed in the treated children 
with CAH (see sections Biological factors influencing behaviour in CAH and Brain 
development in CAH).   
1.4.2.3 Glucocorticoid effects during foetal life 
In the foetal CNS, GCs are essential for normal brain development affecting such 
processes as cell proliferation and neuronal growth and differentiation, but excessive 
levels are known to be detrimental to the CNS (Matthews, 2001). Foetal exposure to 
excess GC can be of different origin, such as maternal stress or maternal treatment 
with synthetic GC.  
In humans, gestational stress and elevated maternal endogenous GC during 
pregnancy have been shown to be associated with developmental delays, behavioural 
abnormalities and emotional problems in children (Huizink, Mulder, & Buitelaar, 
2004; Rice, Jones, & Thapar, 2007; Weinstock, 2001). However, the outcome may 
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also be moderated by genetic risk factors, as well as the postnatal environment 
(Graham, Heim, Goodman, Miller, & Nemeroff, 1999). All trimesters have been 
regarded as vulnerable periods depending on the outcome factor(s) in focus (Huizink, 
et al., 2004; Rice, et al., 2007; Weinstock, 2001). In a prospective study (S. King & 
Laplante, 2005), it was found that the children whose mothers were exposed to 
moderate-high stress during the 1
st
 or 2
nd
 trimester showed significant impairment of 
both general intellectual ability and play behaviour at two years of age, as compared 
to a low-stress group.  
It should be observed that the foetus is normally protected more against 
maternal cortisol than against synthetic GCs because placental enzyme 11βHSD2 
rapidly inactivates most [50–90% (Benediktsson, Calder, Edwards, & Seckl, 1997)] 
of the maternal cortisol to inert cortisone, thus minimizing foetal exposure (Seckl & 
Meaney, 2004), while synthetic GCs, such as betamethasone and DEX, easily cross 
the placenta. It should also be noted that maternal stress also induces other processes 
that could affect the foetus. First, in pregnant primates, the placenta becomes an 
important transient endocrine unit that is activated by maternal stress and acts as a 
source of ACTH, CRH and other hormones (Petraglia, Florio, Nappi, & Genazzani, 
1996). Second, maternal stress also strongly activates the sympathetic-
adrenomedullar system (SAM, Figure 4), which may reduce uteroplacental blood 
flow because catecholamines control vasomotor activity, i.e. the activity which 
controls the size of the blood vessels. Thus, high cortisol levels due to maternal stress 
and medical treatment with synthetic GC may not be completely comparable.  
The effects of synthetic GCs have been studied in children at risk of preterm 
delivery. In this group synthetic GCs are widely used to enhance the maturation of the 
foetal lung in order to avoid respiratory distress. A long-term follow-up study of 
individuals exposed to a single prenatal course of betamethasone showed no effect on 
neurological, cardiovascular, psychiatric or cognitive functions at the age of 30 
(Dalziel, Lim, et al., 2005; Dalziel, Walker, et al., 2005). However, more 
hyperactivity, attention disorders and externalizing problems have been recognized in 
preschool children who received repeated antenatal betamethasone therapy compared 
to children who received a single dose (French, Hagan, Evans, Mullan, & Newnham, 
2004), while general intellectual ability was not affected (French, et al., 2004; 
Wapner et al., 2007). Preterm children with respiratory distress syndrome who 
received a one-week course of postnatal DEX therapy were compared to a placebo 
control group at school age. The DEX group showed significantly poorer motor 
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development, a lower Full-Scale IQ, as well as lower scores on three out of four 
WISC-III Indexes, i.e. Perceptual Organization, Freedom of Distractibility and 
Processing Speed. The Verbal Comprehension Index did not differ between the two 
groups (Yeh et al., 2004). These differences were not detected in an earlier follow-up 
of the same cohort at two years of age (Yeh et al., 1998), thus illustrating the need for 
long-term follow-up studies.  
The pre- and perinatal treatment of preterm children is different from the 
prenatal treatment of children at risk for CAH, and the effects of GCs may also vary 
depending on which synthetic GC is chosen (Baud & Sola, 2007; Heine & Rowitch, 
2009). Nonetheless, studies on the treatment of preterm children may provide 
important information on mechanisms by which synthetic glucocorticoids exert their 
effects. These mechanisms have been studied in more detail in animal models. 
1.4.3 Animal models of foetal glucocorticoid exposure 
Experimental data from animals exposed to prenatal corticosteroids have 
demonstrated adverse effects on somatic development, as well as on cognition and 
other aspects of behaviour. In rats, a range of additional side-effects such as low birth 
weight and hypertension (Celsi et al., 1998); decreased size of the hippocampus and 
affected short-term memory (Seckl & Miller, 1997); impaired learning and memory 
functions (Emgard et al., 2007); alterations in forebrain development as well as 
noradrenergic and cholinergic neurotransmitters (Kreider et al., 2005); persistent 
effects on serotonergic and dopaminergic systems (Slotkin, Kreider, Tate, & Seidler, 
2006); alterations in size and organization of midbrain dopaminergic populations, 
including a feminization or demasculinization of the three-dimensional 
cytoarchitecture in males (McArthur, McHale, & Gillies, 2007); aberrant sexual 
behaviour (Holson, Gough, Sullivan, Badger, & Sheehan, 1995); heightened 
vulnerability to oxidative stress in cerebellar granule cells (Ahlbom, Gogvadze, Chen, 
Celsi, & Ceccatelli, 2000); as well as alteration of two transcription factors known to 
be involved in brain cell differentiation (Slotkin, Zhang, McCook, & Seidler, 1998). 
Reduced exploratory behaviour and behavioural inhibition have also been observed in 
the same species exposed to prenatal DEX treatment either during the entire 
gestational period or during late gestation (Welberg, Seckl, & Holmes, 2001). 
However, the developmental timetable of the foetus differs significantly in rats and 
humans (Bayer, et al., 1993) (Table 1). Many of the brain areas that develop in rat 
from mid- to late gestation are formed in humans during the first trimester of 
   15 
pregnancy, such as certain hypothalamic and hippocampal areas (Bayer, et al., 1993). 
There are also differences in GR distribution in the brain. Primates have more GR in 
the frontal lobes than the levels described in rodents, in which the well-known 
glucocorticoid-hippocampus link was originally established (Patel, et al., 2000; 
Sanchez, et al., 2000). Moreover, rats are considered to be corticosensitive while 
primates are corticoresistant species (Seckl, 2004). 
In rhesus monkeys, a single high dose of DEX in late gestation resulted in 
altered hippocampal architecture. Moreover, multiple injections of DEX over a 24-
hour period caused more severe damage on hippocampal neurons than a single 
injection with the same total dose (Uno et al., 1990). In a study of long-term postnatal 
sequelae, juvenile prenatally DEX-treated (doses of 5 mg/kg) rhesus monkeys had 
significantly higher plasma cortisol at baseline and post-stress than controls, as well 
as a reduction in hippocampal volume (Uno et al., 1994). Prenatal administration of 
DEX to African vervet monkeys was associated with metabolic effects after doses of 
120 and 200 µg/kg/day as well as an exaggerated cortisol response to mild stress after 
doses of 200 µg/kg/day  (de Vries, et al., 2007). Findings in common marmosets 
exposed to DEX (5 mg/kg/day) during early gestation (days 42–48 of a gestational 
period of 144 days) indicate that foetal glucocorticoid overexposure can lead to 
abnormal development of motor and social behaviours (Hauser, et al., 2008).  
As mentioned before, most of the animal models have been designed to 
imitate the perinatal treatment of premature children or have used high doses of DEX. 
Little is therefore known about the effects of prenatal DEX treatment as used in CAH.  
1.5 BEHAVIOURAL ASPECTS OF CAH 
Although the prenatal DEX treatment of CAH is administered in order to reduce or 
avoid virilization of external genitalia in girls with CAH, there are also possible 
effects on the CNS and behaviour. These effects may not only be due to direct 
influence of excess GC but may also be due to a GC effect on sex hormones. Sex 
hormones have a major effect on the development of brain and behaviour. Effects of 
abnormally high levels of prenatal androgens on cognition and different dimensions 
of gender have been studied in individuals with CAH who have not been treated 
prenatally. Consequently, these behaviours may also be affected by the prenatal DEX 
treatment that brings the level of androgens to normal.  
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1.5.1 Cognition and lateralization 
1.5.1.1 Intelligence 
A possibility of selective sampling in clinic-based studies, together with small sample 
sizes, may explain the earlier finding of an elevated IQ in patients with CAH 
(Sinforiani et al., 1994). These results were not confirmed in other studies (Helleday, 
Bartfai, Ritzen, & Forsman, 1994; Kelso, Nicholls, Warne, & Zacharin, 2000; Merke 
et al., 2003). A few studies have found that patients with salt-wasting CAH have 
lower IQs than patients with simple-virilizing CAH (Helleday, Bartfai, et al., 1994; 
Nass & Baker, 1991) or lower than controls (Johannsen et al., 2006). However, no 
association between disease characteristics and intelligence was found in a recent 
study showing no evidence of intellectual deficit in either females or male patients 
with CAH (Berenbaum, Bryk, & Duck, 2010). 
1.5.1.2 Lateralization: handedness 
A higher incidence of left-handedness (Kelso, et al., 2000; Nass & Baker, 1991; 
Tirosh, Rod, Cohen, & Hochberg, 1993) or less consistent right-handedness 
(Mathews et al., 2004) among CAH patients has been found,  thus supporting the 
hypothesis that prenatal androgen exposure causes a shift in cerebral lateralization 
toward right-hemisphere dominance (Geschwind & Behan, 1982; Geschwind & 
Galaburda, 1985). However, not all studies confirm the finding of a higher incidence 
of left-handedness among CAH patients (Helleday, Siwers, Ritzen, & Hugdahl, 1994; 
Malouf, Migeon, Carson, Petrucci, & Wisniewski, 2006). 
1.5.1.3 Sex-specific cognition 
Sex differences have been observed in certain cognitive tasks in children as young as 
3–5 months old (Moore & Johnson, 2008; Quinn & Liben, 2008). Boys perform 
better in some spatial tasks such as mental rotation, while girls perform better in 
certain verbal tasks such as verbal memory and fluency (Halpern, 2000; Kimura, 
2000). These sex differences observed in children, adolescents and adults (ibid.) are 
thought to be influenced by sex hormones (Hines, 2010). Thus, prenatal androgens 
are not only thought to shift lateralization in handedness, but they are also thought to 
exert other organizing effects and influence cognition.  
In females with CAH, it is hypothesized that a shift towards a male-typical 
cognitive pattern could occur. This hypothesis has been supported by studies showing 
better performance in some, although not all, spatial tasks  in girls, adolescents and 
women with CAH as compared to unaffected relatives (Hampson, Rovet, & Altmann, 
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1998; Hines et al., 2003; Resnick, Berenbaum, Gottesman, & Bouchard, 1986), but 
they were not confirmed by all studies (Malouf, et al., 2006). One study of spatial 
navigation ability reported that females with salt-wasting CAH (and an expected 
highest level of in utero exposure to androgens) performed similarly to both control 
males and CAH males, whereas evident sex differences were observed in milder 
forms of the disorder and in controls (Mueller et al., 2008). However, advanced bone 
age (an indicator of long-term childhood exposure to testosterone) was correlated 
with improved spatial navigation, i.e. not only prenatal but also postnatal androgens 
may have influenced spatial ability in these females.  
In males with CAH the picture is different: poorer spatial ability has been 
observed in boys, adolescents and men with CAH as compared to unaffected controls  
(Hampson, et al., 1998; Hines, et al., 2003; Puts, McDaniel, Jordan, & Breedlove, 
2008). The observations of better spatial ability in females with CAH and poorer 
spatial ability in males with CAH, as compared to unaffected sex-matched controls, 
may support the hypothesis of a curvilinear relationship (“inverted U shape”) between 
androgens and spatial performance with intermediate levels of testosterone being 
associated with better spatial functioning (Moffat & Hampson, 1996).  
Apart from spatial abilities, there are few studies on other sex-specific 
cognitive functions in CAH, such as verbal fluency, a cognitive function favouring 
females. However, a few studies showed inferior results in verbal tests in children 
with CAH (Plante, Boliek, Binkiewicz, & Erly, 1996) and women with CAH 
(Helleday, Bartfai, et al., 1994) as compared to controls, and a small study showed 
poorer verbal fluency in girls with CAH than in controls (Inozemtseva, Matute, & 
Juarez, 2008).  
The reason why tests of spatial abilities are the most frequently used measures 
of sex-specific cognition in the CAH literature is probably that the focus has been on 
masculinization rather than defeminization. Moreover, spatial abilities (especially 
mental rotation and targeting) show the largest effect sizes among different measures 
of sex-specific cognition (Hines, 2010). Sex differences are small to medium-sized in 
most functions in which sex differences have been observed and studies of clinical 
groups are often relatively small in size, thus easily resulting in type II problems 
(failing to detect a difference due to low statistical power). However, what can be 
inferred from the existing studies on the effect of prenatal androgens is that boys and 
girls should be considered separately when analysing results in neuropsychological 
tests and other aspects of behaviour. 
 18 
1.5.1.4 Learning disabilities 
A risk for learning disabilities in CAH has been hypothesized for two reasons. First, 
there are possible risk factors due to disease complications in the neonatal period but 
also later, such as hypoglycaemia and salt crisis (see the section Biological factors 
influencing behaviour in CAH). Second, there is a possible negative effect of excess 
prenatal androgens on learning abilities, which has been hypothesized to result in the 
male predominance among children with learning disabilities, as suggested by the 
Geschwind-Belan-Galaburda (GBG) theory (Geschwind & Behan, 1982; Geschwind 
& Galaburda, 1985).  
A specific deficit in computation ability has been reported (Nass & Baker, 
1991), but not confirmed by other studies. Likewise, a small study showed elevated 
rates of reading disabilities in girls with CAH as compared to controls (n = 11 in both 
groups) (Inozemtseva, et al., 2008). Although there is not much evidence that patients 
with CAH are more likely to have learning disabilities (of clinical significance i.e. 
possible to diagnose) compared with their CAH-unaffected relatives, it should be 
noted that this issue has not been well studied with appropriate assessments. It is also 
possible that learning disabilities occur in children with severe and poorly treated 
CAH (due to disease complications), but not generally in the CAH population. 
However, a study in 11 children with CAH, their 5 CAH-unaffected siblings and 16 
controls suggested a high rate of language/learning disabilities in both children with 
CAH and their CAH-unaffected siblings as compared to controls (Plante, et al., 
1996). The authors suggested that the language/learning disability seemed to be a 
familial one and may be related to elevated androgen levels since also in CAH-
unaffected heterozygote siblings androgens may be  elevated, although to a lesser 
degree than in CAH-affected individuals (New et al., 1983). Moreover, a potential 
hormonal contribution of a heterozygote mother to the foetus may affect the 
developing CNS, and there might also be a possible linkage between the CAH genes 
and one or more genes in the adjacent region on chromosome 6 that may affect brain 
development and subsequent language/learning skills (Plante, et al., 1996).  
1.5.1.5 Social cognition  
In an fMRI study (discussed in more detail below in the section Brain development in 
CAH) (Ernst et al., 2007), the CAH group showed poorer differentiation of adverse 
emotions (anger or fear) from neutral facial expression as compared to healthy 
controls. Impairments in social cognition may affect social interactions negatively. In 
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a study on the association between high levels of prenatal testosterone and later 
autistic traits measured with the Autism Spectrum Quotient (AQ) rating scale, 
females with CAH scored significantly higher than their CAH-unaffected female 
relatives (Knickmeyer et al., 2006). Females with CAH reported especially high 
scores (more problems) in subscales measuring social skills and imagination.  
It should be observed that these results could indicate just another aspect of 
masculinization of the brain and behaviour since there are also sex differences in the 
normal population. With regard to social perception, females have been shown to be 
more adept than males (Wood, Heitmiller, Andreasen, & Nopoulos, 2008; Wood, 
Murko, & Nopoulos, 2008). Thus, the differences between females with and without 
CAH do not necessarily indicate autistic traits. This is, however, an interesting area of 
research and not much is known about the effects of the prenatal androgens on social 
cognition. A recent study has shown an association between prenatal androgens 
(measured in the umbilical cord) and development of social communication (or 
“pragmatic language”) in healthy girls (Whitehouse et al., 2010), but this has not been 
studied in girls with CAH.  
1.5.2 Dimensions of gender 
In contrast to earlier unidimensional theories of gender typing, recent theories 
emphasize the importance of integrating disparate perspectives and multiple 
dimensions of gender (Didonato & Berenbaum, 2011). Gender role behaviour, 
sometimes called sex-typical behaviour (the behaviour typical of one gender versus 
the other in a given historical time and place), is not synonymous with gender role 
identification/sex role identification, which refers to the child‟s self-perception of 
gender-related personality disposition (Boldizar, 1991), i.e. identification with a 
masculine or feminine sex role or “psychological masculinity or femininity”. 
Moreover, gender role behaviour is differentiated from sexual orientation, i.e. the 
overall responsiveness to male versus female sex partners, not necessarily identical 
with the gender of the actual partner(s) or with the sexual identity as a heterosexual, 
homosexual or bisexual. Gender identity is yet another dimension of gender and 
refers to the basic sense of belonging to the male or female gender or something else, 
for instance, an intersex identity (Meyer-Bahlburg, 2001). Additional dimensions or 
components of gender and gender development are sex-specific cognition (mentioned 
in the section Cognition and lateralization in CAH), as well as sex differences in 
psychopathology and personality (Blakemore, Berenbaum, & Liben, 2009). 
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1.5.2.1 Gender-role behaviour 
There is great variability in gender-role behaviour in the general population. This 
variability is probably accounted for by a number of factors such as gender-related 
genes, hormonal mechanisms (pre- and postnatal) and psychosocial factors or 
socialization. When compared with their sisters or other same-sex controls, females 
who have CAH engage in more male-typical childhood play, have more male-typical 
interests in adolescence, are more likely to report the use of physical aggression in 
conflict situations, are less interested in infants, marriage, motherhood and feminine 
appearance, score lower on measures related to empathy, intimacy, the need for social 
relations, maternal/nurturant behaviour and succorance, and are more likely to choose 
male-typical vocations (Berenbaum, 2001; Berenbaum, Duck, & Bryk, 2000; 
Berenbaum & Resnick, 1997; Dittmann, Kappes, Kappes, Borger, Meyer-Bahlburg, 
et al., 1990; Dittmann, Kappes, Kappes, Borger, Stegner, et al., 1990; Hines, 2006, 
2010; Meyer-Bahlburg, 2001; Meyer-Bahlburg et al., 2004b; Nordenstrom, et al., 
2010; Nordenstrom, Servin, Bohlin, Larsson, & Wedell, 2002). These behaviour 
shifts have been observed also in girls and women who are treated with GC from 
infancy on (Meyer-Bahlburg, 2001). There is also a dose-response relationship 
between disease severity and degree of masculinization of behaviour in girls with 
CAH (playing with gender-role atypical toys) (Berenbaum, et al., 2000; Nordenstrom, 
et al., 2002). These results are considered to support the view that prenatal androgen 
exposure has a direct organizational effect on the human brain so as to determine 
certain aspects of sex-typed behaviour. 
Nonetheless, there are also critics who argue that the physical differences in 
girls with CAH may lead their parents into treating them differently from CAH- 
unaffected girls, i.e. (not necessary consciously) influencing their behaviour in the 
male direction. Opposing these assumptions are results from a study using structured 
toy-play observation as an assessment method;  when parents played with their 
daughters with CAH, they did not influence them to play in a more masculine way, 
but rather the opposite (Nordenstrom, et al., 2002).  
1.5.2.2 Sexual orientation 
Most women with CAH are heterosexual, but the rates of bisexual and homosexual 
orientation are increased compared to CAH-unaffected female relatives (Dittmann, 
Kappes, & Kappes, 1992; Meyer-Bahlburg, Dolezal, Baker, & New, 2008). The 
concept of bisexual/homosexual orientation refers to behaviours such as sexual 
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imagery, sexual attraction, and, to a lesser degree, overt homosexual involvement 
(Meyer-Bahlburg, 2001). Bisexual/homosexual orientation was not only predicted by 
the degree of prenatal androgenization (Frisen, et al., 2009; Meyer-Bahlburg, et al., 
2008), but also by masculinization of childhood behaviour in women with CAH 
(Meyer-Bahlburg, et al., 2008).  
1.5.2.3 Gender identity 
While changes in gender-role behaviour and sexual orientation can be related to the 
severity of the disease, and therefore to prenatal androgenization (Cohen-Bendahan, 
van de Beek, & Berenbaum, 2005; Hines, 2006; Nordenstrom, et al., 2002; Servin, 
Nordenstrom, Larsson, & Bohlin, 2003), much less is known about what determines a 
person's gender identity (Meyer-Bahlburg, et al., 2004b). In girls and women with 
CAH, gender identity does not seem to be affected in most cases, although the 
observed percentage of serious problems with gender identity (5.2%) is higher than 
the prevalence of female-to-male transsexuals in the general population of 
chromosomal females (Dessens, Slijper, & Drop, 2005).  
1.5.2.4 Sex differences in personality 
Personality has been studied in CAH with regard to traits that usually show a sex 
difference, such as aggression. Males are more likely than females to show aggressive 
behaviour across species, ages and situations, and these differences have been 
hypothesized to be influenced partly by early hormones (Berenbaum & Resnick, 
1997). Using questionnaires completed by mothers as the method of assessment, it 
has been observed that 3 to 11-year-old girls with CAH are more aggressive and 
active than their CAH-unaffected sisters, while there were no differences between 
boys with CAH and their CAH-unaffected brothers (Pasterski et al., 2007). As 
expected, unaffected boys were more aggressive and active than unaffected girls 
(ibid.). Corresponding results were observed in another study showing higher 
aggression in adolescent and adult females with CAH than in CAH-unaffected 
relatives (Berenbaum & Resnick, 1997). In this study, the difference in children 
(CAH-affected compared to non-CAH relatives) was not statistically significant and 
the sample sizes were quite small.  
In a Swedish study (Helleday, Edman, Ritzen, & Siwers, 1993), 22 women 
with CAH were compared to 22 controls on the  Karolinska Scales of Personality 
(KSP) (Schalling & Edman, 1993). It has been observed earlier that 8 out of 15 KSP 
subscales show significant sex differences (ibid.), and the CAH group differed 
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significantly on two of these eight scales, both in a masculine direction (Helleday, et 
al., 1993). Thus, the CAH group showed a high, male-level score for Detachment 
(distance in social relations as reflected by behaviours such as avoiding involvement 
in other people‟s personal life; not getting close to people) and a lower score for 
Indirect Aggression (reflected by behaviours such as slamming of doors, spreading 
gossip about people one dislikes) as compared to female controls.  
A recent study included both males and females with CAH (age ranging from 
12 to 45 years), as well as their CAH-unaffected relatives as controls, and focused on 
four aspects of personality: physical aggression, dominance, tender-mindedness and 
interest in infants (Mathews, Fane, Conway, Brook, & Hines, 2009). Females with 
CAH were less tender-minded and reported more physical aggression and less interest 
in infants compared to female controls. Males with CAH were less dominant, more 
tender-minded and reported less physical aggression than control males (ibid.).  
1.5.3 Psychological well-being and perception of health 
Children and young adult females with CAH did not differ from CAH- unaffected 
female relatives on parental ratings of psychopathology (the Child Behaviour Check 
List, CBCL), self-rating of positive versus negative emotionality, or self-image 
(comprising aspects of psychopathology and adjustment) (Berenbaum, Korman Bryk, 
Duck, & Resnick, 2004). In the same study, males with CAH were not different from 
unaffected males, with the exception of  more reported negative affect at older ages 
(ibid.). Correspondingly, women with CAH have been reported to be psychologically 
well adjusted and they did not show increased psychiatric illness or deficits in social 
adjustment compared to population data (Morgan, et al., 2005). However, in a 
controlled study, women with CAH reported a poorer quality of life as well as more 
affective distress than  controls (Johannsen, Ripa, Mortensen, & Main, 2006).  
Yet, in another controlled study, general psychological well-being did not 
differ between women with CAH and controls (Frisen, et al., 2009). However, with 
regard to specific disease-related questions, one third of the women with CAH 
reported that the disease affected their relationship with their partner since they 
reported feeling “inhibited” or “ashamed of the appearance of my genitals”. In a 
population-based follow-up of all Norwegian adult patients with CAH (Nermoen, 
Husebye, Svartberg, & Lovas, 2010), it was observed that women with CAH had only 
21% of the expected number of children compared with the general population. 
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Moreover, 40% of the women with CAH (age range 19–80 years) reported that they 
had never had a gynaecological investigation as an adult (ibid.).  
In the aforementioned study on personality (Helleday, et al., 1993), a non-
significant trend (.05 < p < .10) was observed in the subscale Psychasthenia 
consisting of items such as “in order to get something done, I have to spend more 
energy than most others” and “I think I must economize my energy”. In the more 
recent population-based study (Nermoen, et al., 2010), perception of general health 
and vitality were especially deteriorated in the CAH group (consisting of 72 of 101 
identified patients), although scores on all eight subscales of the instrument used (SF-
36 Health Survey) indicated significant impairment as compared to normative data 
from the Norwegian general population. However, among the quality of life scores, 
only one of the 16 items (item no.2: health, being physically fit and vigorous) was 
significantly lower than the norm (ibid.).  
The literature on psychological well-being, psychosocial adjustment and self-
perceived health may seem to be contradictory.  However, the focus of the studies and 
assessment methods used vary between the studies and may at least partly explain the 
differences. Many of the standard instruments used are not devised to capture body-
image or sexuality-related problems. Also, studying younger age groups may not 
show possible problems with sexuality, especially not problems related to sexual 
function that become apparent at older ages. The use of collateral information and 
rating scales, such as the CBCL, may not capture difficulties observed in clinical 
interviews (Wassenberg, Max, Koele, & Firme, 2004). Based on a clinically 
structured diagnostic interview, the Kiddie Schedule for Affective Disorders and 
Schizophrenia – Present and Lifetime Version (KSADS-PL), a high prevalence of 
attention-deficit hyperactivity disorder (ADHD) has been reported among boys with 
CAH (18.2%) (Mueller et al., 2010), which can be compared to the prevalence of 
approximately 5% in population-based studies (an approximately 3 boys : 1 girl 
ratio), although choice of informant, criteria for symptom count, definitions of 
subtypes and gender differences influence the prevalence estimates of ADHD 
(Ullebo, Posserud, Heiervang, Obel, & Gillberg, 2011). Mueller et al (2010) also 
observed an increased rate of disruptive behaviour disorders in boys with CAH. In 
girls with CAH, ADHD was observed in 4.8%, i.e.  not more often than in the 
population. However, both girls and boys with CAH showed increased rates of 
anxiety disorders relative to the population norm (ibid.). The study consisted of 
relatively small samples, and additional studies, also including a non-psychiatric 
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control group, are needed. Since rating scales such as the CBCL are known to be less 
sensitive than clinical interviews (Wassenberg, et al., 2004), epidemiological studies 
based on symptom ratings may also underestimate the prevalence of psychiatric 
problems in the population, thus impeding comparisons between clinical studies and 
population-based epidemiological studies.  
1.5.4 Biological factors influencing behaviour in CAH 
It is important to note that the prenatal androgens and prenatal DEX treatment are not 
the only biological factors influencing behaviour in CAH-affected children. Brain 
development and behaviour may be affected by changes in hormones such as excess 
prenatal exposure to androgens and adrenocorticotropic hormone (ACTH) and 
reduced cortisol. Before appropriate (postnatal) treatment is established, children may 
be at risk of salt-wasting and hypoglycaemia, which can adversely affect the brain. 
Previously, before all neonates were screened for CAH, complications were likely to 
be more severe in males than in females due to later diagnosis and treatment. In 
Sweden, all neonates have been screened for CAH since 1986.  
When treated, individuals with CAH may be exposed to excess 
glucocorticoids because of the difficulties mimicking the diurnal rhythm of cortisol 
production (LWPES/ESPE, 2002). Moreover, GC replacement therapy not only 
influences levels of cortisol but also levels of other hormones such as ACTH, which 
in turn may have an impact on cognition (Veith, Sandman, George, & Kendall, 1985). 
Hypotension, dehydration and hyponatraemia can result in cognitive impairment in 
patients with salt-wasting syndrome (Nass & Baker, 1991). Therefore, all behavioural 
data on prenatally DEX-treated children at risk for CAH should also be analyzed 
separately for children who are CAH-affected and treated postnatally.   
1.5.5 Brain development in CAH 
White matter abnormalities, which did not correlate with clinical or cognitive 
characteristics, were observed in 4 out of 15 patients (27%) who underwent magnetic 
resonance imaging (Sinforiani, et al., 1994). Similarly, the white matter abnormalities 
and/or temporal lobe atrophy observed in 18 out of 39 patients (46%) were not 
associated with age, type of CAH (salt-wasting versus simple virilizing) or treatment 
status (under- or oversuppression; compliance) as analysed using a series of chi- 
square tests (Nass et al., 1997). In addition, 8 of 39 patients with CAH were noted to 
have Chiari malformations and 9 of 39 patients had an abnormality of the pituitary 
region (ibid.). Likewise, 4 out of 7 patients had abnormalities of the pituitary on MRI 
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despite standard GC replacement therapy (Speiser, Heier, Serrat, New, & Nass, 
1995). Moreover, patients with CAH showed high basal ACTH levels as well as 
ACTH hyperresponsiveness to oCRH stimulation test, and the authors suggested that 
the inevitable periods of under- and overexposure to GC in CAH patients may, over 
time, cause abnormalities of the HPA axis (ibid.).  
Not all studies report white matter abnormalities in CAH: in a small study in 
which scans of 7 patients with CAH, their 3 CAH-unaffected siblings and 10 controls 
were read by a neuroradiologist blinded to the subjects‟ identity, no white matter 
abnormalities in CAH cases were observed (Plante, et al., 1996). However, an 
atypical pattern of perisylvian asymmetries was observed in the majority of CAH 
patients and in all of their siblings, and the authors suggest an elevated familial rate 
for language-based learning disabilities (see also the section Learning disabilities).   
In a more recent study (Bergamaschi et al., 2006), half of the patients were 
subjected to a long-term follow-up with repeated scanning (they were included in the 
previous cohort, Sinforiani et al., 1994) while the other half were included and 
scanned for the first time. Ten (45%) out of 22 patients with CAH had white matter 
abnormalities on MRI and the MRI findings did not change over time in the subjects 
who were scanned a second time. The authors suggest that hormone imbalance during 
brain maturation may be involved in the white matter abnormalities; it has been 
observed that GCs influence the proliferation of oligodendrocyte precursors 
(oligodendrocytes‟ main function is the insulation of the axons in CNS with myelin, 
i.e. the white matter) (Alonso, 2000). Moreover, corticosteroid replacement 
treatments could also contribute to white matter abnormalities. Supraphysiological 
doses of GC are sometimes required to suppress adrenal androgen production and 
these high doses could interfere with normal myelination (Huang, Harper, Evans, 
Newnham, & Dunlop, 2001). Bergamaschi et al. (2006) also suggested that 
aldosterone deficiency in CAH could lead to subclinical cerebral ischaemia 
(microangiopathic/microvascular damage) since aldosterone has a direct local 
regulatory function on the cerebral arterial structure.  
Areas of the brain known to be affected by hormones of the HPA axis and 
androgens are of special interest in brain imaging studies of CAH. Merke et al. (2003) 
studied the cerebrum, ventricles, temporal lobe, hippocampus and amygdala in a 
structural MRI study in 27 children with CAH and 47 controls. A significant decrease 
in amygdala volume was observed in both males and females with CAH as compared 
to sex- and age- matched controls; however, the effect size in girls (Cohen‟s d = 1.56) 
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was almost twice as large as in boys (d = .91). The organizational effects of 
androgens on the development of the CNS were suggested to be the most likely 
explanation of these findings. The amygdala is dense in androgen receptors 
(DonCarlos, Garcia-Ovejero, Sarkey, Garcia-Segura, & Azcoitia, 2003) and 
androgens modulate amygdala size in animals and humans (Goldstein et al., 2001). 
The authors also suggest that prenatal GC deficiency with resulting alterations in 
HPA axis regulation or some combination of sex steroid excess and GC deficiency 
may contribute to the growth and development of the amygdala (Merke, et al., 2003). 
In the same study, adverse effects on the hippocampus due to GC therapy were not 
observed in children with CAH.  
In another study from the same research group (Ernst, et al., 2007), a virilized 
amygdala function was observed in girls with CAH using functional MRI, while no 
differences were observed between boys with CAH and controls. More specifically, 
in response to negative facial emotions, girls with CAH activated the amygdala 
bilaterally significantly more than healthy female controls, and the pattern in 
activation was similar to that in control boys (ibid.). However, when the same study 
group was analysed in an extended fMRI study (Mazzone et al., 2011), boys with 
CAH also showed a different activation pattern compared to controls. When fMRI 
data were analysed with regard to successfully encoded fearful faces, boys with CAH 
showed significant activations in the amygdala, hippocampus, and anterior cingulate 
relative to unaffected males, while girls with CAH demonstrated deactivations 
relative to unaffected females in the same regions. The CAH group showed poorer 
memory performance than the controls. In an another extended study,  the same 
research group found memory deficits for negatively arousing pictures in both males 
and females with CAH compared to healthy controls (Maheu et al., 2008), while there 
were no group differences in memory recall for positive or neutral pictures. These 
finding suggest that an early steroid imbalance may affect memory for negative 
material in children with CAH.  The hormonal dysfunctions during critical periods of 
development may lead to abnormal brain organization and function. The sample sizes 
were also small in the extended studies. 
In the above-mentioned structural MRI study, girls with CAH did not have 
male-specific CNS characteristics (Merke, et al., 2003). In contrast, a male-typical 
pattern of activation was observed in adolescent girls with CAH in the inferior 
parietal lobule (LPI) in a functional MRI study from the same research group (Ernst, 
et al., 2007). The LPI has been associated with sex differences in visual-spatial 
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abilities (Gron, Wunderlich, Spitzer, Tomczak, & Riepe, 2000). These results 
supported the hypothesis of an early organizational effect of testosterone on brain 
function in girls with CAH. In the same study, a general effect of CAH diagnosis (i.e. 
an effect across sex) was observed on the fusiform gyrus, a structure that processes 
visual social stimuli such as faces and body movements. The authors suggested that 
these results reflect impaired corticosteroid function rather than an effect of sex 
steroids since the effect is disease-specific (main effect of CAH) rather than sex-
specific (interaction effect).  
Taken together, several studies have shown white-matter abnormalities in 
both females and males with CAH. A hypothesized mechanism behind these 
abnormalities is impaired myelination due to endogenous hormonal imbalance or 
supraphysiological GC replacement therapy, or both, together with possible 
additional mechanisms such as microangiographic damage related to an aldosterone 
deficiency. However, a clear association between the white-matter abnormalities and 
disease-related factors (such as type of CAH, SW versus SV) has not been shown. 
Moreover, the functional implications of the white-matter anomalies are not known. 
In addition to white-matter abnormalities, recent series of studies have shown 
abnormalities in structure and function of the amygdala, together with behavioural 
correlates (impaired social cognition).  
 
1.6 LONG-TERM FOLLOW-UP STUDIES OF PRENATAL DEX 
TREATMENT OF CAH  
Long-term developmental effects of prenatal DEX treatment of children at risk for 
CAH have been assessed in two previous studies, both designed as parental 
questionnaire studies. A pilot study suggested that prenatally DEX-exposed pre-
school children showed more shyness, greater emotionality, less sociability and more 
internalizing problems (Trautman, Meyer-Bahlburg, Postelnek, & New, 1995), while 
a study focusing on parent-rated cognitive and motor development could not find any 
significant negative effects (Meyer-Bahlburg et al., 2004a). These studies are 
described in more detail in the section General Discussion. Studies with direct 
assessments of the DEX-treated children are lacking.  
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2  AIMS  
The aims of the thesis were to examine whether prenatal exposure to DEX affects the 
following aspects of development:  
1. Cognition and school performance (Study I) 
2. General adaptation, temperament, or long-term affective development, 
especially social anxiety (Study II) 
3. Gender role behaviour (Study III) 
– as part of the study on gender role behaviour, to develop and 
evaluate a new assessment instrument (Studies III and IV) 
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3 METHODS 
 
3.1 STUDY POPULATIONS AND PROCEDURES 
In Sweden, between the years 1985 and 1995, 40 foetuses at risk of being affected 
with severe CAH were treated with dexamethasone from postmenstrual week 6 to 7 
until the prenatal diagnosis was available to prevent prenatal virilization of affected 
females (Lajic, et al., 1998). Treatment was offered to women who have previously 
given birth to a child with severe CAH. The maximum dose was 20 µg/kg per day, 
based on pre-pregnancy maternal weight, divided into three doses. Based on the 
results of a mutation analysis in chorionic villus biopsies at weeks 10 to 12, the 
treatment was discontinued if the foetus was male or an unaffected female, whereas 
CAH-affected female foetuses were treated until term. All families were first 
contacted by means of an invitation letter containing two information letters, one for 
the parents and one for the child. The final cohort comprised 26 children (12 boys, 14 
girls; refusal rate 35%) between 7 and 17 years old (M = 10.95, SD = 2.33 years).  
The studies included in this thesis were retrospective. Thus, none of the 
families were initially treated within the framework of a clinical study, and this fact is 
most probably the major reason for the relatively high refusal rate (35%). To analyse 
whether there were any differences between the families/children that took part in the 
study, as compared to those who refused participation, we performed an analysis of 
the two groups using data from a previous questionnaire study on the same population 
(Lajic, et al., 1998), as well as data collected from the managing paediatrician. The 
composition of the cohort that participated in the study did not differ from that of the 
children/families that refused participation with regard to (1) behavioural problems of 
the child; (2) psychosocial problems in the family; (3) maternal side-effects induced 
by DEX; and (4) the maternal attitude towards future treatment.   
The DEX-exposed children – both CAH-unaffected and those with CAH – 
were compared to sex and age-matched healthy controls. The controls were recruited 
from two sources. First, siblings of children treated with growth hormone (with 
presumed similar psychosocial prerequisites to those of the study group, i.e. having 
an older sibling on long-term medical treatment) were included: 10 (four boys and six 
girls) out of 28 children (refusal rate 64%) between 7 and 12.5 years of age (9.94 ± 
2.02). Second, in order to create a large enough control group, the Swedish National 
Registry was used to randomly recruit 25 children matched for age and sex (11 boys 
 30 
and 14 girls, refusal rate 69%) between 7 and 17 years old (10.55 ±  2.46). Data from 
these control groups were used in Studies I, II and III. Since there were no differences 
between the two control groups (siblings to the growth hormone-treated children 
versus children recruited through the Swedish National Registry) on any of the 
measures, the controls were combined to form a single control group.  
 
 
Figure 5. Participants in studies I-III comprised of 26 DEX exposed children and 35 age- 
and sex-matched controls. In studies III-IV, data from an additional control group of 180 
children was used to evaluate a new assessment instrument. 
 
No somatic examination was performed in the control group, while in the 
CAH group, somatic diseases were known from their case files: one CAH-affected 
boy had had diabetes mellitus since 2 years of age; one unaffected girl had 
rheumatoid arthritis; and another unaffected, short-term treated girl was under 
investigation for proteinuria. One CAH-affected girl was not able to complete the 
neuropsychological tests due to low intellectual performance (Study I), but parental 
questionnaires were obtained for this child (Study II). 
Among the DEX-treated children, 54% lived in cities in comparison with 97% 
of the controls (χ2 test, p < 0.001). There were no significant differences in parental 
socioeconomic status as estimated by parental educational level (χ2 test, p = 0.162) 
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between the two groups. Moreover, the treated versus non-treated children were 
comparable regarding birth length, birth weight and gestational length (all ps < 0.10).  
In Studies III and IV, data from an additional „group of 180 school-age 
children was used. This group was recruited to evaluate the Karolinska Inventory of 
Gender Role Behaviour (KI-GRB), developed for the current project. The children 
were recruited from two schools: one school in Stockholm, with 4309 habitants/km
2
 
(Statistics Sweden: www.scb.se), and one in Enköping, a small town with 33 
habitants/km
2 
(ibid). In total, 180 children from 13 different classes took part in the 
study. In Study III, data from children from grade 2 to 6 (i.e. the same age range as 
for most children in the other study groups) were analysed, while in Study IV, all 180 
children took part.  
In Studies I, II and III, the same clinical psychologist performed the 
standardized assessments for all families. The neuropsychological tests were 
administered in a fixed order and the questionnaires were completed by the children 
and their parents when visiting the clinical psychologist. Thus, both parents and 
children had the opportunity to ask for clarification of items (Achenbach, 1991). 
Parents and children completed the questionnaires independently of each other. In 
Studies III and IV, all data from the 180 children were collected by the same person, 
who had a MSc degree in psychology. The questionnaires and the cognitive tests 
were completed in a fixed order. Children who were 8 years old (grade 2) completed 
the tasks individually with the test leader and could thus get help with the reading and 
comprehension of the items. Children from grade 4 to 8 were tested in their class- 
rooms, so that all participating pupils from the same class completed the tasks at the 
same time.  
 
3.2 ASSESSMENT OF BEHAVIOUR 
3.2.1 Neuropsychological tests 
The neuropsychological tests used in the projects are well-standardized and 
frequently used assessment instruments with good psychometric properties. General 
intellectual ability, or IQ, was assessed in Study I using a short version (Donders, 
1997) of the Wechsler Intelligence Scales for Children – IV (WISC-III) (Wechsler, 
2003). Learning and memory were assessed using the Developmental 
Neuropsychological Assessment (NEPSY) (Korkman, Kirk, & Kemp, 1998). 
Moreover, a test of spatial memory was administered (Anderson, Lajoie, & Bell, 
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1997). Manual preference, a test of handedness, is from a previous version of the 
NEPSY test battery (Korkman, 1988). Executive functions were assessed using 
subtests of Wechsler scales (Kaplan, Fein, Morris, & Delis, 1991; Wechsler, 2003) 
and the Stroop test (Golden & Freshwater, 1998).  
The Wechsler Intelligence Scale for Children – IV (Wechsler, 2003) has been 
normed in Sweden and the index scores and scaled scores were used in order to 
facilitate comparison with the population mean.  However, the Span Board test is not 
included in the WISC – III, and these raw scores were transformed into scaled scores 
using the norm tables for the corresponding verbal test, Digit Span, from WISC – III. 
The NEPSY test has been normed in Sweden, but the manual does not include the 
scaled scores (the comparison with the population norm is done using percentile 
intervals), and to enable comparison between the different tests, we transformed the 
NEPSY raw scores into scaled scores according to the American manual (Korkman, 
et al., 1998). Also, although not normed in Sweden, the results in the Stroop Color 
and Word Test (Golden & Freshwater, 1998) were transformed into T-scores for the 
sake of simplicity. The results of the statistical analyses were analogous using the raw 
data or the T-scores.   
 
3.2.2 Questionnaires 
Children’s self-rating scales were used in Studies I, II and IV. The children estimated 
their scholastic ability by completing a subscale from the Self-Perception Profile for 
Children (Harter, 1985). The children also completed the Social Anxiety Scale for 
Children–Revised (SASC-R) (la Greca, Dandes, Wick, Shaw, & et al., 1988). 
Children‟s Sex Role Inventory, CSRI (Boldizar, 1991), was used in Studies III and IV 
to measure sex role identification.  
Parental rating scales were used in Studies I and II. The Child Behavior 
Checklist for Ages 4–18 (Achenbach, 1991) was used for parental evaluation of the 
children‟s scholastic performance, adaptive functioning and behavioural problems. 
Parents also completed the Social Phobia and Anxiety Inventory for Children – 
Parental Rating (SPAI-C-P) (Beidel, Turner, & Morris, 1995; Higa, Fernandez, 
Nakamura, Chorpita, & Daleiden, 2006), while children‟s temperament was measured 
indirectly via parental ratings of the Emotionality-Activity-Sociability-Shyness 
Temperament Survey for Children (EAS) (Buss & Plomin, 1984).  
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3.2.3 Other behavioural assessment instruments  
The Karolinska Inventory of Gender Role Behaviour (KI-GRBI) was developed for 
the current project. The KI-GRB surveys children‟s favourite toys, activities, same-
sex versus other-sex friends and preferred future occupation. Thus, behavioural 
dimensions of gender are assessed with open-ended questions posed directly to the 
child. 
 
3.3 STATISTICAL METHODS 
In study I, a series of analyses of variance (ANOVA) was used to compare the 
prenatally treated children with healthy controls. In case of significant differences, the 
analyses were re-run for three groups, i.e. the healthy controls, prenatally DEX- 
treated CAH-unaffected children and prenatally DEX-treated CAH-affected children 
also treated postnatally with synthetic GC. This allowed us to compare healthy 
controls with otherwise healthy DEX-treated children (Figure 5). 
In Study II, most of the variables were strongly positively skewed (i.e. many 
low ratings) and therefore non-parametric statistics were applied. DEX-exposed 
children were compared to unexposed children using the Mann-Whitney U-test, while 
categorical data were analysed using χ2 tests. Statistically significant findings were re-
evaluated using the Kruskall-Wallis test for comparisons of the three groups: DEX- 
treated CAH-unaffected children, DEX-treated CAH-affected children and controls. 
The first part of Study III was focused on evaluation of the KI-GRB using 
data from 160 school-age children. Correlation analyses were used for inter-rated 
agreement (Pearson‟s correlation and Interclass Correlations, ICC). Underlying 
dimensions of the KI-GRB were studied using a principal component analysis (PCA) 
with varimax rotation. The KI-GRB subscales (Masculine, Feminine and Neutral 
behaviours) were correlated with corresponding categories in Children‟s Sex Role 
Inventory, CSRI (Boldizar, 1991).  
In Study IV, developmental trajectories (effect of age/grade), sex differences 
as well as sex by grade interaction effects were analysed using two-way ANOVAs. 
Moreover, Pearson‟s correlations as well as multiple regression analyses were used to 
study the association between the different dimensions of gender.  
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4 ETHICAL CONSIDERATIONS 
4.1 ETHICAL DILEMMA WITH THE TREATMENT 
The prenatal DEX treatment of children at risk for CAH harbours an ethical 
dilemma since 7 out of 8 foetuses (and their mothers) are treated in early pregnancy 
without any obvious benefit. This is why the prenatal DEX treatment is considered 
controversial and has been debated in the scientific literature (Brook, 2000; Miller, 
1999; New, 2001).  
Based on rather few (mostly short-term) follow-up studies (Lajic, 
Nordenstrom, & Hirvikoski, 2008), the treatment has been considered almost totally 
free of side-effects (Forest, Morel, & David, 1998; New, 2001), while based on the 
same literature, other authors have called attention to possible long-term sequelae 
(Miller, 1998) and encouraged large prospective controlled studies which include 
careful long-term follow-ups (Ritzen, 1998). In Sweden, this kind of study has been 
taking place since 2000 as part of a European prospective multicentre study (Lajic, et 
al., 2004). However, since it takes many years before the results of this kind of 
extensive long-term prospective study will be available, the retrospective study 
presented in the current thesis was undertaken.  
4.2 ETHICAL DILEMMA WITH THE RETROSPECTIVE STUDY DESIGN 
To perform a retrospective study constituted further ethical dilemmas; many of the 
mothers commented that they had not even thought about the prenatal treatment since 
it had been administered, and it was possible that the participation in the study caused 
some worry among the families. Moreover, it is possible that not all of the treated 
children knew that they had been treated prenatally, and this kind of information after 
several years may have been both disturbing and confusing for them (and possibly 
one reason for the relatively high refusal rate since some parents also may have 
chosen not to tell their children about the treatment).  
Not performing a follow-up would, however, leave the families (and us) with 
even greater uncertainty and the benefits of conducting the study were considered to 
weigh more heavily than the drawbacks; or, in other words, it was considered a 
greater ethical dilemma not to offer a long-term follow-up for the treated children and 
their families.  
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4.3 FORMAL ETHICAL APPROVAL  
All children and their parents were given oral and written information about the aims 
and procedures of the studies before the examinations. They were also informed that 
the participation was voluntary. The names of the participants were replaced with 
registration numbers and/or codes to ensure anonymity. Approval from the Research 
Ethics Committee of Karolinska Institutet and the Stockholm Research Ethics 
Committee was obtained before the studies were begun.  
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5 RESULTS  
5.1 COGNITION AND SCHOLASTIC PERFORMANCE (STUDY I) 
Parental ratings of overall school performance (Child Behaviour Check List School 
Scale) showed good scholastic competence in the DEX-exposed group as compared 
to controls.  Thus, there were no differences between the two groups with regard to 
need for special teaching or occurrence or problems in school. These results were in 
accord with the normal performance in all measures of learning and long-term 
memory from the NEPSY observed in the direct neuropsychological assessment of 
DEX-treated children and controls (Hirvikoski et al., 2007) (Figure 6). In addition to 
the NEPSY subtests, there were no differences between the DEX-exposed children 
and the controls in the test of spatial memory (memory for locations) (Anderson, et 
al., 1997), although, in this test, ceiling effects were observed.   
 
Figure 6. There were no differences between the DEX-treated children and controls in the 
NEPSY tests of learning and memory.  
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Moreover, DEX-exposed children had comparable results to those of controls 
in measures of psychometric intelligence, i.e. full-scale IQ, as well as the Verbal 
Comprehension Index, Perceptual Organization Index and Speed of Processing Index. 
However, in the Freedom of Distractibility Index, a significant difference was 
observed between the DEX-treated children and the control group, which was 
indicative of a negative effect on verbal working memory (Figure 7).   
 
Figure 7. The DEX exposed group performed significantly more poorly than the control 
group in Freedom of Distractibility Index while the other indices did not show any 
statistically significant differences between the two groups.   
A more detailed analysis of the test included in the Freedom of Distractibility 
Index showed that the between-group difference reached significance in the Digit 
Span Test, a test of verbal working memory. This difference remained significant also 
on controlling for FSIQ and social anxiety in an analysis of covariance. Pair-wise 
post hoc comparisons showed that both CAH-affected and CAH-unaffected DEX- 
treated children had lower results in the Digit Span tests compared to controls (Figure 
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8). After the Bonferroni correction for multiple comparisons, the difference remained 
significant only for the CAH-unaffected, short-term treated children. However, as can 
be observed in Figure 8, this may have been simply due to a small sample size in the 
CAH-affected group (treated with DEX prenatally and hydrocortisone postnatally); 
the mean values were basically the same for both DEX-treated groups. In addition, a 
non-significant statistical trend in the Span Board Test, a measure of visual-spatial 
working memory, was observed. However, since this group difference did not reach 
significance, no further analysis of this test was performed.  
 
Figure 8. The CAH unaffected DEX exposed children performed poorer than the controls in 
the Digit Span test, while the difference between the CAH affected children and the control 
group no longer reached significance in the post hoc tests.  
 
As already mentioned, the DEX-treated children did not differ from the 
controls on the parent-rated CBCL School Scale. However, scholastic ability was also 
measured as self-rating using the Scholastic Competence subscale from The Self-
Perception Profile for Children (Harter, 1985), and in these self-ratings DEX-exposed 
children reported significantly lower results compared to controls. Moreover, 
children‟s self-perceived scholastic ability correlated positively with verbal working 
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memory capacity measured by the Digit Span Test (r = .41, p = .004). Thus, the 
children who reported low self-perceived scholastic ability were those who performed 
less well on the Digit Span Test (Figure 9).   
 
Figure 9. Verbal working memory capacity measured with the Digit Span test correlated 
positively with children‟s self-perceived scholastic ability (r = .41, p = .004).  
The Stroop Colour Word Test consists of three subtests; speeded reading, 
speeded naming of colours and colour word/interference, a measure of impulse 
inhibition. The DEX-treated group had significantly lower results in both speeded 
reading and speeded naming of colours; however, when adjusted for FSIQ these 
differences no longer reached significance. Likewise, a non-significant tendency to a 
lower speed of processing in the DEX-treated group seemed to be an effect of slight 
(non-significant) differences in IQ and, consequently, dropped to below p > .20 when 
IQ was entered as a covariate in an ANCOVA.  
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In the NEPSY Manual Preference, a trend (p = .067, Figure 10) showed more 
consistent right-handedness in the DEX-treated group (n = 25), including CAH- 
affected children; in this group all children (n = 8) performed all tasks included in the 
test with the right hand, the standard deviation thus being zero (0). Categorized as 
left- or right-handedness, none of the DEX-treated children and three children in the 
control group were left-handed (2 x 2 χ 2 test, p = .13). However, in behaviours that 
seldom occur – 10% of the normal population are left-handed (Gilbert & Wysocki, 
1992) – a larger study group may be needed in order to attain statistical power and 
reach significance.  
 
Figure 10. The DEX-exposed group showed a tendency to more consistent right-
handedness. However, this difference did not reach significance (p = .067), probably due 
to low power.  
 
 
5.2 ADJUSTMENT, WELL-BEING AND TEMPERAMENT (STUDIES I - II) 
Parental ratings showed good overall adjustment in DEX-exposed children, as 
compared to controls, regarding both general competence and psychological well-
being. Thus neither the CBCL total competence score nor any of the problem 
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subscales differed between the DEX-treated group and the control group (both ps < 
.10) (Figure 11).  
 
Figure 11.  There were no statistically significant differences between the DEX-exposed 
group and the control group in the CBCL problem subscales.  
 
No between-group differences were observed with the exception of results 
from the Sociability scale in the Emotionality Activity Shyness Temperament Survey 
for Children (Buss & Plomin, 1984). In this measure, CAH-unaffected children who 
were treated short-term were rated as slightly more sociable than the controls by their 
parents. CAH-affected girls and boys were rated similarly to controls.  
Owing to the results in the pilot study by Trautman et al. (1995) suggesting 
that DEX-exposed children showed more shyness, greater emotionality, less 
sociability and more internalizing problems, we had a special focus on social anxiety 
among other behavioural problems. In the Swedish cohort, increased social anxiety 
was observed in the self-ratings (Social Anxiety Scale for Children – Revised, SASC-
R) (Figure 12). However, when analysed for three groups (CAH-unaffected, CAH- 
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affected and controls), only the CAH-unaffected, short-term-treated group differed 
significantly from the controls.  
 
Figure 12. The CAH-unaffected DEX-exposed group reported more social anxiety than 
controls. 
Note: Only children ≥ 8 years old completed the self-rating questionnaires.  
 
The observed differences in the children‟s self-ratings of social anxiety were 
not confirmed in parental ratings of social anxiety. No differences between the DEX- 
treated and the control group were observed in the Social Phobia and Anxiety 
Inventory for Children – Parent Report (SPAI-C-P) or on the EAS Shyness subscale. 
These parental ratings showed a strong correlation with each other (r = .57) while the 
correlation between parental ratings of social anxiety (SPAI-C-P) and the children‟s 
self-ratings of social anxiety (SASC-R) was weaker (r = .31). The modest parent-
child agreement on social anxiety is consistent with previous studies on cross-
informant agreement (Achenbach, McConaughy, & Howell, 1987).  
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5.3 GENDER ROLE BEHAVIOUR (STUDIES III-IV) 
 
Gender role behaviour was investigated in the last part of the project. In order to 
measure gender role behaviour, a new inventory was designed (the Karolinska 
Inventory of Gender Role Behaviour, KI-GRB), and therefore evaluation of this new 
inventory was performed partly in Study III and in Study IV. Here, the results on the 
KI-GRB as such are described first, followed by the results in DEX-treated children 
and the sex- and age-matched controls.  
In Study III, the KI-GRB was compared with a widely used  instrument 
developed to measure another aspect of gender: the Children‟s Sex Role Inventory, 
CSRI (Boldizar, 1991). A principal component analysis with a varimax rotation 
showed that the underlying dimensionality of the KI-GRB was clearly described by 
the three subscales (Feminine, Masculine and Neutral behaviours); the first factor 
included the Feminine (positive loading) and Masculine (negative loading) subscales 
and the second the Neutral behaviours subscale. Contrary to the results in the KI-
GRB, the PCA of the CSRI revealed a one-factor solution, indicating that all 
subscales measure the same underlying dimension. Moreover, children‟s sex 
explained a very large proportion of variance in the KI-GRB Feminine and Masculine 
subscales, while the effect sizes were smaller in the CSRI (the Ki-GRB Feminine 
subscale, ηp
2 
=  .44; the CSRI Feminine subscale, ηp
2 
=  .17; the KI-GRB Masculine 
subscale, ηp
2 
=  .42; the CSRI Masculine subscale, ηp
2 
=  .07). Finally, the KI-GRB 
scores showed a significant interaction between the child‟s sex and residential area 
(urban/rural living), indicative of a socialization effect on gender role behaviour. 
Girls in small towns/rural areas reported more feminine behaviours than girls in urban 
areas, while boys in rural areas showed less feminine behaviours than boys in urban 
areas (ηp
2 
= .11, a medium-sized effect). Correspondingly, boys in small towns/rural 
areas reported more masculine behaviours than boys in urban areas, while girls in 
rural areas showed fewer masculine behaviours than girls in urban areas (ηp
2 
= .08, a 
medium-sized effect).  
In Study IV we investigated sex differences and the developmental 
trajectories in, as well as associations between, three dimensions of gender: gender 
role behaviour (the KI-GRB), sex-specific cognition (the Verbal fluency test, VFT; 
the Mental rotation test, MRT) and sex role identification (the CSRI) in 180 school-
age children. We observed sex differences in all dimensions of gender. The effect of 
sex was largest in the KI-GRB (gender role behaviour). 
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Sex differences in gender role behaviour were not stable across time: children in 
grades 5 and 6 (11–13 years old) reported the least stereotypical patterns in GRB – 
although also in these ages, the effects of sex were large on both Feminine and 
Masculine subscales, both ds > 1. Both older (grade 8: 14–15 years old) and younger 
(grades 2 and 4: 8–11 years old) children showed very large sex differences in 
masculine and feminine behaviours. The largest sex differences were observed in 
grade 4 (on the KI-GRB Feminine subscale, d = 5.77; on the KI-GRB Masculine 
subscale, d = 7.31). Moreover, GRB correlated with both cognitive tests (VFT and 
MRT) in girls and with the MRT in boys, while sex role identification was not 
associated with the other dimensions of gender.  Thus, the dimensions of gender did 
not develop in isolation, but the developmental trajectories were related to each other. 
This could imply that anything that influences one dimension of gender, such as 
gender role behaviour, may also have direct or indirect effects on other dimensions of 
gender, such as sex-specific cognition, or vice versa.  
The main focus of the studies on gender role behaviour was, however, not on 
the new instrument (KI-GRB), but on the possible effects of prenatal DEX treatment 
on gender role behaviour as measured with the new instrument.  The focus of this 
study was on the CAH-unaffected short-term treated children, although all analyses 
were also recalculated including CAH-affected children. The DEX-exposed CAH- 
unaffected children showed a non-significant tendency to less masculine behaviours 
(p = .13). Moreover, there was a larger variation in the behaviour of the DEX-treated 
CAH-unaffected boys on all three KI-GRB subscales. The DEX-exposed CAH- 
unaffected boys also showed more neutral behaviours than the control boys, while the 
DEX-treated CAH-unaffected girls did not differ from the control girls after adjusting 
for the residential area. This interaction effect was medium-sized (ηp
2 
= .10). An 
analogous result was obtained when all DEX-exposed children (also CAH-affected) 
were included.  
 
 
 
 
Figure 13. Correlation between rater 1 and rater 2 on the KI-GRB three subscales. Inter-
rater reliability was good for feminine and masculine behaviours, and moderate for neutral 
behaviours. (Previous page). 
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6 GENERAL DISCUSSION 
 
The fact that the prenatal dexamethasone treatment of children at risk for CAH has to 
be started early in pregnancy, i.e. several weeks before the diagnostic status of the 
foetus is known, leads to unnecessary treatment in 7 out of 8 treated cases (CAH-
unaffected children and boys with CAH). This is the basis of the great ethical 
dilemma of the treatment: can we tolerate any negative effects in children that do not 
need the treatment? For girls with CAH, possible side effects could be weighed 
against the advantages of the treatment, such as reduction or elimination of 
virilization in the external genitalia, and thus possibility avoiding surgical corrections 
and possible problems with body-image and sexual function. However, in CAH- 
unaffected girls and all boys, there are no gains with the treatment and, consequently, 
tolerance for negative effects should be low.  
Considering the ethical dilemma connected with the prenatal DEX treatment 
of CAH together with the disturbing results from animal studies, it is surprising that 
so few long-term follow-up studies have been conducted. The ethical dilemma and 
concerns with the treatment have been recognized in recent reviews (Merce 
Fernandez-Balsells et al., 2010; Vos & Bruinse, 2010); however, only two research 
groups have conducted original follow-up studies. Specifically, prior to our studies, 
only two studies have been published and none of these was based on direct 
examination of the treated children but on collateral information (parent-completed 
questionnaires). A pilot study designed as a postal maternal questionnaire survey 
studied psychological well-being in the DEX-treated children (Trautman, et al., 
1995), while an extended questionnaire study by the same researchers (Meyer-
Bahlburg, et al., 2004a) focused on parent-reported cognitive and motor outcomes. In 
the latter study, data on psychological well-being were not reported. A comparison of 
our studies with these previously published studies is complicated because different 
assessment methods have been used in different age groups (Table 2). In total, five 
studies have now been published: two reports focus mainly on behavioural problems 
and temperament (Hirvikoski et al., 2008; Trautman, et al., 1995), two focus on 
cognitive and motor development as well as school performance (Hirvikoski, et al., 
2007; Meyer-Bahlburg, et al., 2004a) and one pilot study on gender role behaviour 
(Hirvikoski, Lindholm, Lajic, & Nordenstrom, 2011) (Table 2).  
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Table 2. Summary of the long-term follow-up studies on prenatal dexamethasone 
treatment of children at risk for congenital adrenal hyperplasia.  
 Participants Results from different assessment methods 
 DEX- 
exposed 
children 
Control 
group 
Parental 
questionnaires 
Direct assessment of the children  
Trautman 
& al. 
(1995) 
n = 26 
(3 CAH-
affected) 
 
n = 14 
Untreated 
children at 
risk for 
CAH (3 
CAH-
affected) 
No differences 
in general 
development 
(R-
DPDQ/MCDI) 
or 
temperament 
(ITQ/TTQ/ 
BSQ). DEX- 
treated 
children had 
higher scores 
on Shyness 
and 
Emotionality, 
lower on 
Sociability 
(EAS), and 
more 
Internalizing 
and Total 
Problems 
(CBCL). 
N/A 
 
 
Age reported for the total 
study group  
(n = 40): 6 months – 5.5 
years old 
Mean age  = 2.5 (±1.3)  
years 
Meyer-
Bahlburg 
et al. 
(2004) 
n = 36 
0–15 
months 
old 
 
n = 15 
0–15 
months 
old 
No differences 
on general 
development 
(KIDS/ R-
DPDQ) 
N/A 
n = 89 
15 months  
to 6 y old 
n = 126 
15 months  
to 6 y old 
No differences 
on general 
development 
(CDI/R-
DPDQ) 
N/A 
n = 44 
6–12 y old 
n = 162 
6–12 y old 
No differences 
on school 
performance 
(CBCL School 
scale) 
N/A 
Total n = 
174 (48 
CAH-
affected: 31  
girls, 17 
boys) 
Total n = 
313 
(195 CAH-
affected: 
100 girls, 
95 boys) 
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 Participants Results from different assessment methods 
 DEX- 
exposed 
children 
Control 
group 
Parental 
questionnaires 
Direct assessment of the children  
Hirvikoski 
et al. 
(2007) 
n = 26 
7-17 y old 
M = 10.95 
(± 2.33) 
(9 CAH-
affected: 4 
girls, 5 
boys) 
 
n = 35 
7-17 y old 
M = 10.38 
(± 2.33) 
Healthy 
controls 
No differences 
on school 
performance 
(CBCL School 
scale) 
CAH-unaffected children reported 
poorer scholastic competence 
(SPPC) and increased social 
anxiety (SASC-R). 
No differences in IQ (WISC-III), 
handedness, learning or memory 
(NEPSY). CAH-unaffected 
children had poorer working 
memory (WISC-III). 
Hirvikoski 
et al. 
(2008) 
Same cohort as 
Hirvikoski et al. (2007) 
 
No differences 
on behavioural 
problems or 
adjustment 
(CBCL). No 
differences on 
shyness 
(SPAI-C-P). 
DEX-treated 
children had 
higher scores 
on Sociability 
(EAS). 
Correlation between parental 
(SPAI-C-P) and children‟s self-
ratings (SASC-R) of social anxiety 
shyness was modest.  
Hirvikoski 
et al. 
(2011) 
n = 26 
7–17 y old 
M = 10.95 
(± 2.33) 
(9 CAH-
affected: 4 
girls, 5 
boys) 
 
n = 35 
7–17 y old 
M = 10.38 
(± 2.33) 
Healthy 
controls 
 
 
 CAH-unaffected DEX-treated 
boys showed more neutral 
behaviours than the controls (KI-
GRB) while CAH-unaffected 
DEX-treated girls did not differ 
from the controls after adjusting 
for residential area. A non-
significant tendency to less 
masculine behaviours in the DEX- 
treated CAH-unaffected children 
was observed.   
Note: R-DPDQ = Revised Denver Prescreening Developmental Questionnaire; MCDI = Minnesota Child 
Development Inventory; CBCL = Child Behaviour Checklist; ITQ = Infant Temperament Questionnaire; 
TTQ = Toddler Temperament Questionnaire; BSQ = Behavioural Style Questionnaire; EAS = EAS 
Temperament Survey for Children; KIDS = Kent Infant Development Scale; CDI = Child Development 
Inventory; WISC-III = Wechsler Intelligence Scales for Children; NEPSY = Develop- mental 
Neuropsychological Assessment; SPPC = Self-Perception Profile for Children; SASC-R = Social Anxiety 
Scale for Children–Revised; SPAI-C-P =  Social Phobia and Anxiety Inventory for Children – Parent 
Report;  KI-GRB = Karolinska Inventory of Gender Role Behaviour.  
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Thus, a pilot study designed as a postal maternal questionnaire survey 
suggested that prenatally DEX-exposed preschool children showed more shyness, 
greater emotionality and less sociability, as well as more internalizing problems 
(Trautman, et al., 1995). Data on the children‟s temperament or behavioural problems 
were not presented in the extended questionnaire study by the same researchers 
(Meyer-Bahlburg, et al., 2004a). Our cohort comprised school-age children 
(Hirvikoski, et al., 2008) and used the same questionnaires when applicable. No 
between-group differences were observed in the parental ratings with the exception of 
results from the Sociability scale in the Emotionality Activity Shyness Temperament 
Survey for Children. Regarding this measure, children who were treated with DEX 
were rated as slightly more sociable than the controls by their parents; however, on 
comparing three groups (CAH affected, CAH unaffected and controls), this difference 
did not reach significance, probably due to low power. On examining the mean 
values, it was observed that the CAH-unaffected, short-term-treated group showed 
higher scores on Sociability than the other two groups.  
In our results (Study II), no differences were observed in parent-rated shyness 
or social anxiety, and thus our results did not confirm the results of Trautman et al. 
(1995). However, in the Swedish cohort, increased social anxiety was observed in the 
CAH-unaffected, short-term-treated group when self-rated.  Consequently, the 
correlation between parental ratings and children‟s self-ratings was weak.  The 
modest parent-child agreement on social anxiety is consistent with previous studies 
on cross-informant agreement (Achenbach, et al., 1987). Given that parents and 
children focus on different aspects of child psychopathology, multi-source assessment 
procedures are recommended (Achenbach, et al., 1987). The sensitivity of different 
assessment methods is another important consideration when comparing different 
studies. Questionnaires are often less sensitive than structured clinical interviews in 
capturing clinical problems (Wassenberg, et al., 2004), let alone in identifying 
subclinical effects that are even more difficult to detect, but may still result in 
impairment in everyday life when the child encounters new or challenging tasks or 
during a stressful period of life.  
In the previous study focusing on cognition and motor development (Meyer-
Bahlburg, et al., 2004a), no differences were observed in the parental ratings between 
the DEX-treated children and controls. In addition, there were no differences in 
parental ratings of the school performance of DEX-exposed, school-age children 
(Child Behaviour Check List School Scale) as compared to controls in either of the 
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two published studies (Hirvikoski, et al., 2007; Meyer-Bahlburg, et al., 2004a). These 
results were in accord with the normal performance in major cognitive measures such 
as IQ, learning and long-term memory observed in our study using direct 
neuropsychological assessments of DEX-treated children and controls (Hirvikoski, et 
al., 2007). Nevertheless, specific negative effects were noted regarding verbal 
working memory and on the children‟s perceptions of their scholastic competence 
(Hirvikoski, et al., 2007) and these effects remained significant also on controlling for 
full-scale IQ and social anxiety. In addition, a non-significant statistical trend in a 
measure of visuo-spatial working memory was observed.  
Working memory is one of the key executive functions. It is the ability to 
maintain information for a mental operation during a short period of time (Baddeley, 
1986). At school, WM is important for such abilities as mental arithmetic and reading 
comprehension. Moreover, WM is crucial for the executive components of the 
learning situation, for example, organizing and planning, and the ability to remember 
instructions while using them to guide one's own behaviour. Not unexpectedly, in our 
material, verbal WM capacity was significantly correlated with children‟s self-
perception of their scholastic ability. However, parental scoring of school 
performance was not associated with WM capacity.  
Thus, regardless of the observed large effect sizes  for the differences in 
verbal working memory (Cohen‟s d = .95) and children‟s self-perceived scholastic 
competence (Cohen‟s d = .82) in our study (Hirvikoski, et al., 2007), there were no 
differences in the number of DEX-treated children (versus controls) who attended 
special classes  or special schools, had repeated a class or had “any academic or other 
problems in school”, as reported by their parents. Likewise, we could not detect an 
elevated rate of learning disability diagnoses, such as dyslexia, among the DEX- 
exposed children. These results indicate subclinical effects on WM and scholastic 
performance, regardless of the “large” effect sizes. In this context it should also be 
noted that, according to Cohen (Cohen, 1988) (p.25), “The terms „small‟, „medium‟, 
and „large‟ are relative, not only to each other, but to the area of behavioural science 
or even more particularly to the specific content and research method being employed 
in any given investigation.”  
It is possible that children with a somewhat lower WM capacity (i.e. not in a 
clinical range but slightly lower than that of their age group), as in the current study, 
may reach the same results as same-age peers although through an extra effort. 
Therefore, subjectively, they may perceive a lower scholastic capacity as a result of 
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the increased strain while their parents and teachers may note normal performance in 
school work.  
Working memory functions are bilateral prefrontal functions; however, verbal 
WM is predominantly associated with effective connectivity in the left prefrontal 
cortex, whereas visuo-spatial WM functions are primarily related to the right 
prefrontal cortex (Arnsten, 2006; Schlosser, Wagner, & Sauer, 2006). Moreover, the 
catecholaminergic and dopaminergic prefrontal subcortical networks and the 
connectivity of the prefrontal regions with certain temporal (in the verbal WM) and 
parietal (in the visual-spatial WM) regions, as well as cerebellar regions, are 
implicated in working memory (ibid.). Hence, like most complex cognitive functions 
and other behaviours, working memory emerges from a neural network and not from 
a single brain structure. 
The last part of the project focused on gender role behaviour in prenatally 
DEX-treated children at risk for CAH. Parental rating scales are often used to assess 
gender role behaviour. Using parental questionnaires may, however, lead to partly 
biased responses: for example, it is known that parents perceive their daughters and 
sons differently also when there are no differences in behaviour (Mondschein, 
Adolph, & Tamis-LeMonda, 2000). Alternatives to parental rating scales were 
inventories that provide the child with lists of activities and toys that are rated as 
desirable or non-desirable, a procedure that may lead to demand characteristics. 
Demand characteristics refer to an unconscious systematic change in behaviour due to 
the study participants‟ interpretation of the experiment's purpose.  
Because of the lack of a suitable assessment instrument, we also developed a 
short, structured inventory to survey gender role behaviour in school-age children. 
This inventory, the Karolinska Inventory of Gender Role Behaviour (KI-GRB), was 
evaluated in an additional sample of 180 school-age children. We concluded that the 
inter-rater agreement was good for masculine and feminine behaviours and moderate 
for neutral behaviours. The results of the principal component analysis supported the 
underlying dimensions of the inventory, i.e. clearly described the three subscales of 
the KI-GRB. Sex differences were very large in both KI-GRB Feminine and KI-GRB 
Masculine subscales, although there was also a significant effect of age. Children 
who were 11 to 13 years old reported the least stereotyped pattern in GRB (although 
the ES for masculine and feminine behaviours were still > 1.0, i.e. a large effect), 
while both younger (8–10 years old) and older (14–15 years old) children showed 
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very large sex differences in both feminine (d = 3.33–5.77) and masculine (d = 2.53–
7.31) behaviours.  
Moreover, we observed a medium-size effect of living area (urban/rural) on 
gender role behaviour, indicative of a socialization effect. Children‟s results on the 
KI-GRB subscales correlated with both cognitive tests in girls (Verbal fluency test, 
VFT, and Mental rotation test, MRT) and with the MRT in boys. Thus, the 
dimensions of gender did not develop in isolation, but the developmental trajectories 
were related to each other. Consequently, anything – biological or sociocultural 
factors or both - that has an impact on one dimension of gender may not only have an 
isolated effect on that dimension but may also affect other aspects of gender 
development.  These effects may be direct (the factor influencing both dimensions 
simultaneously) or indirect (an influence on one dimension may lead to later effects 
on another dimension, for example, through practicing effects).  
The main focus of Study III was on the effects of the prenatal DEX treatment 
on GRB. We chose to focus on the CAH-unaffected, short-term-treated children (i.e. 
the children who do not benefit from the prenatal treatment per se), but we also 
performed all analyses including the CAH-affected children treated both pre- and 
postnatally with GC. We observed a larger variability in the DEX-treated boys on all 
three KI-GRB subscales, as compared to controls. DEX-exposed, CAH-unaffected 
boys also showed more neutral behaviours than the control boys, while the DEX- 
treated, CAH-unaffected girls did not differ from control girls after adjusting for the 
site of residence. There was also a non-significant tendency (p = 0.13) to less 
masculine behaviours in the CAH-unaffected, DEX-treated children. Recalculation of 
the analyses including the CAH-unaffected children showed analogous results.  
The possible effects could be due to a direct effect of excess GC or to a GC 
effect on sex hormones, or a combination of both. A reduction in testosterone has 
been observed in rats after prenatal DEX treatment (Lalau, Aubert, Carmignac, 
Gregoire, & Dupouy, 1990), while there are no human studies on this subject. In the 
current study, androgens were not measured during the treatment and therefore we do 
not know how the DEX treatment affected androgens in the short-term-treated, CAH- 
unaffected children. Certain indirect markers of prenatal androgens have been used in 
research, such as the 2D:4D digit ratio (Puts, et al., 2008), although the validity of 
this marker has been questioned (Hickey et al., 2010). Another marker of the prenatal 
androgen level is handedness. According to the Geschwind-Behan-Galaburda theory 
(GBG) (Geschwind & Behan, 1982; Geschwind & Galaburda, 1985), high prenatal 
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androgen exposure inhibits development of the left hemisphere and causes a shift in 
cerebral lateralization towards right-hemisphere dominance, thus increasing the 
incidence of left-handedness or weaker dextrality. In support of this theory, a higher 
incidence of left-handedness has been observed among CAH patients in most studies 
(see Introduction). However, in addition to the CAH studies, the evidence for the 
association between high prenatal androgens and left-handedness is scarce 
(Vuoksimaa, Eriksson, Pulkkinen, Rose, & Kaprio, 2010). On the contrary, there are 
also studies showing an association between higher levels of prenatal testosterone, as 
measured in amniotic fluid, and increased right-handedness in girls (but not in boys) 
(Grimshaw, Bryden, & Finegan, 1995), thus supporting the callosal theory, meaning 
that left-handedness is caused by decreasing levels of testosterone that affect 
structural and functional development of temporoparietal regions of the brain, such as 
structure of the isthmus of the corpus callosum and the functional asymmetry in this 
region (Witelson & Nowakowski, 1991). Also, there are theories (focusing on other 
behaviours than handedness) which postulate that the relationship between androgens 
and sex-specific cognition, such as mental rotation ability, is curvilinear (“inverted U 
shape”), indicating that intermediate levels are associated with optimal performance. 
Thus, both prenatal (Grimshaw, Sitarenios, & Finegan, 1995; Puts, et al., 2008; 
Vuoksimaa, et al., 2010) and postnatal (Gouchie & Kimura, 1991; Moffat & 
Hampson, 1996) androgens have been suggested to correlate positively  with spatial 
ability in females, but negatively with spatial ability in males. Consequently, also 
with regard to handedness, any effect on prenatal androgen levels could have 
different consequences for girls and boys. To sum up, there are different theories 
about the association between prenatal androgens and the development of handedness 
(or cognition) and the use of indirect measures of prenatal androgens has not been 
validated. Thus we do not know much about the prenatal androgen levels of 
prenatally DEX-treated children at risk for CAH.  
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7 CONCLUSIONS 
On performing a long-term follow-up of prenatal dexamethasone treatment of 
children at risk for CAH, it was concluded that the general adjustment of the treated 
children was good. Major cognitive measures, such as IQ, learning and memory, 
showed normal results for the DEX-exposed children as compared to sex- and age- 
matched controls, as well as population norms. However, a possible negative effect 
on verbal working memory was observed – especially among CAH-unaffected short-
term-treated children, i.e. children who do not benefit from the treatment – and the 
verbal WM capacity correlated positively with the children‟s self-perceived 
difficulties in scholastic capacity. In measures of temperament, psychopathology and 
psychological well-being, no differences between DEX-treated children and controls 
were observed in parental ratings, with the exception of DEX-exposed children being 
rated as being more sociable by their parents as compared to controls. Regarding 
shyness, no differences between the DEX-exposed group and controls were observed 
in parental ratings, while in the children‟s self-ratings, the CAH-unaffected, short-
term-treated children reported more shyness than children in the control group. To 
measure gender role behaviour, a new instrument was developed and evaluated in an 
additional group of school-age children. In DEX-exposed CAH-unaffected short-term 
treated boys, more neutral behaviours were observed as compared to control boys, 
while the DEX-treated CAH-unaffected girls did not differ from the control girls after 
adjusting for the site of residence.  
Taken together, these studies indicate that prenatal DEX treatment of CAH 
probably does not cause major behavioural problems, while there may be some 
effects on executive functions, social anxiety (shyness) and possibly on gender role 
behaviour (in boys). However, a small sample size, a relatively high refusal rate and 
the retrospective design of the studies limited the conclusiveness of the results. 
Studies comprising larger cohorts are needed.  
The possible negative effects in our studies were observed either in the DEX- 
treated group as a whole or in the short-term-treated, CAH-unaffected children. The 
latter group does not benefit from the treatment per se and therefore no side-effects 
should be tolerated. In Sweden, we have decided to put the prenatal DEX treatment of 
CAH on hold until our findings have been either replicated or contradicted in other 
cohorts and larger study groups.  
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We hope that other centres will also conduct long-term retrospective follow-
up studies on all treated children, as well as prospective studies on ongoing 
treatments. In this way our results could be replicated or challenged, as well as 
meaningful meta-analyses may be performed to obtain more conclusive results. These 
results would guide clinicians and investigators in their decisions on the future of the 
prenatal DEX treatment of children at risk for CAH. Until then, families should be 
offered thorough information on the benefits as well as possible side effects of the 
treatment. 
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8 FUTURE PERSPECTIVES 
The results of the studies in this thesis have contributed to the decision to put the 
prenatal DEX treatment of CAH in Sweden on hold. In other countries, the 
controversial treatment is still administered while follow-up studies are scarce.  
It should be noted that prenatal effects on the foetus do not have to affect birth 
weight in order to have imprinting effects on the CNS (de Vries, et al., 2007). 
Moreover, symptoms may not become obvious until later in life. Thus, additional 
long-term follow-up studies of individuals treated with DEX are essential. Moreover, 
future studies should not only focus on major cognitive abilities and gross 
developmental milestones, but also on more subtle effects. General intellectual 
development, learning and long-term memory are of course essential for everyday 
functioning, but other aspects, such as executive functions (for example, response 
inhibition, working memory and set shifting) should be investigated in greater detail 
over time because between 5 and 13 years of age there is a rapid development of 
many key executive functions,  such as working memory (Korkman, et al., 1998; 
Nichelli, Bulgheroni, & Riva, 2001; Westerberg, Hirvikoski, Forssberg, & Klingberg, 
2004), although it is also known from recent brain imaging studies that the human 
CNS continues to mature at least up to the age of 25 (Lenroot & Giedd, 2006; Shaw 
et al., 2008). Development of temperament, psychological well-being and dimensions 
of gender (such as gender role behaviour, sex-specific cognition) should also be 
further investigated.  
Another important area for future studies is vulnerability to stress. The GC 
programming of the HPA axis does indeed occur in primates (de Vries, et al., 2007). 
Synthetic GCs given during pregnancy affect the HPA axis at the level of the brain, 
the pituitary and the adrenal gland, possibly via modulation of the GC and the 
mineralocorticoid receptors (Kapoor, et al., 2008). The effects may be exerted via 
facilitated CRF signalling in the amygdala (Meaney, Szyf, & Seckl, 2007).  A direct 
impact on specific brain structures is not the only factor that may affect cognitive 
performance, since HPA-axis activity is also implicated in the regulation of arousal 
and cognition (which in turn are associated with each other). In animal studies, 
indications of sex differences with respect to prenatal DEX treatment and HPA 
function and feedback regulation have been observed (Banjanin, Kapoor, & 
Matthews, 2004; Liu, Li, & Matthews, 2001).  
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Sex differences may also occur in possible effects on behaviour, including 
cognition, while not much is known about prenatal treatment in CAH. Sex differences 
as well as individual differences in vulnerability – together with the likely subclinical 
nature of the effects - may complicate the interpretation of data and require large 
study groups. In addition to HPA-axis regulation of the CNS, an impact on the 
neurotransmitters or white matter may also affect signalling and connectivity and 
hence complex cognitive functions and behaviours that emerge from neural networks.  
The potential GC programming of the HPA axis may not only alter stress 
reactivity but may also be associated with the metabolic syndrome. The risk factors 
for metabolic and cardiovascular disease (such as lipid profile, glucose metabolism, 
kidney function and blood pressure) should be investigated. Finally, epigenetics has 
attracted increasing interest with regard to GC regulation and long-term imprinting 
effects. Selective methylation and demethylation can permanently alter gene 
expression (Meaney, et al., 2007), and the changes can be inherited to the next 
generation. Transgenerational effects have been demonstrated in the rat  (Drake, 
Walker, & Seckl, 2005). Whether or not these effects take place in connection with 
prenatal DEX treatment in humans remains to be investigated. 
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